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Abstract
Introduction: In prospective cohort studies, information on lifestyle and dietary habits is 
generally only assessed at the baseline examination, assuming that these habits are relatively 
constant over the entire study period. Repeated measures can take into account changes in 
these habits, reduce measurement error due to a reduction in within-subject variation, and can 
give more insight into the etiology of diseases. The main objective of this thesis is to assess the 
relationships of recent and long-term exposure to known lifestyle and dietary risk factors with 
cardiovascular mortality and life expectancy. 
Methods: We used data from the Zutphen Study, a prospective cohort study among 1373 men 
born between 1900 and 1920. These men were examined repeatedly in seven examination 
rounds between 1960 and 2000. In addition to hazard ratios (HR), we presented some of our 
results in terms of differences in life expectancy at age 50. 
Main findings on lifestyle factors: We found that both the number of cigarettes smoked and 
smoking duration were strongly associated with mortality risk. Compared to never or long-term 
former smoking, cigarette smoking decreased life expectancy by about 7 years and exclusive 
cigar or pipe smoking decreased life expectancy by about 5 years. Stopping smoking cigarettes 
at age 50 increased life expectancy by 3.3 years. Furthermore, we observed that long-term light 
alcohol intake, i.e. <20 grams per day, compared to no alcohol intake, lowered cardiovascular 
(HR: 0.70 [95% confidence interval: 0.55 to 0.89]) and all-cause (HR: 0.75 [0.63 to 0.91]) 
mortality risk. Compared to men who do not consume alcohol, wine consumers had a 5 years 
longer life expectancy. 
Main findings on dietary factors: We observed that average trans unsaturated fatty acid 
intake decreased from 7 to about 1 percent of energy intake between 1960 and 2000 and that 
each additional 2 percent of long-term energy intake from trans unsaturated fatty acids was 
positively associated with sudden coronary death (HR: 1.62 [1.01 to 2.60]). In contrast, long-
term fatty fish consumption was inversely associated with sudden coronary death (HR: 0.46 
[0.27 to 0.78]). The strength of the association between long-term total fish consumption and 
coronary heart disease (CHD) death decreased from age 50 (HR: 0.32 [0.13 to 0.80]) until age 
80 (HR: 1.34 [0.58 to 3.12]). We observed no clear dose-response relationship between the 
intake of the n-3 fatty acids EPA and DHA, and (sudden) coronary death. Finally, we found that 
each additional 10 grams of recent dietary fiber intake was associated with a lower risk of CHD 
(HR: 0.83 [0.70 to 0.98]) and all-cause (HR: 0.91 [0.82 to 1.00]) mortality. 
Conclusions: The studies described in this thesis emphasize the importance of lifestyle and diet 
for public health. Our results suggest that non-smoking and a low level of wine consumption 
decrease the risk of (cardiovascular) mortality and will increase life expectancy at age 50. The 
long-term consumption of fatty fish and the reduction in long-term trans unsaturated fatty acid 
intake may prevent sudden coronary deaths, and a higher recent dietary fiber intake may reduce 
both CHD and all-cause mortality risk.
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Chapter 1
Introduction
Changes in life expectancy
Between 1960 and 1970, life expectancy at birth among Dutch men was relatively constant, 
i.e. about 71 years. After that, life expectancy at birth increased steadily to 78 years in 2007 
(figure 1.1). For life expectancy at age 50, the same trend was seen. A major determinant for 
the increase in life expectancy is the decrease in risk of dying from cardiovascular diseases, 
such as coronary heart disease and cerebrovascular diseases (1). It is expected that, for men, life 
expectancy at birth will increase to 81.5 years in 2050 (2).
Cardiovascular and (sudden) coronary heart disease
In the Netherlands, cardiovascular diseases (CVD) are the second leading cause of death among 
men. In 1980, more than 50% of the men dying from CVD, died from coronary heart disease 
(CHD) and about 20% died from cerebrovascular diseases (figure 1.2) (3). In 2007, about 
one-third of the men died from CHD and another one-third from cerebrovascular diseases (3). 
CHD is characterized by a lack of blood and oxygen in the heart and surrounding tissue. Athero-
thrombosis is the underlying process for the occurrence of CHD. The clinical manifestations 
of atherosclerosis are the consequence of thrombotic complications on disrupted or ruptured 
atherosclerotic lesions. The risk of suffering a thrombotic complication depends more on the 
composition and instability of the atherosclerotic lesions than their stenotic severity (4-6). 
Major risk factors for CHD are age, genetics (7), unhealthy diet (8), lack of physical activity 
(9), smoking (10), high alcohol intake (11), obesity (12), diabetes mellitus (13), high blood 
pressure (14), high LDL cholesterol and low HDL cholesterol (15;16), and high levels of 
inflammation markers such as C-reactive protein (17). Changes in these risk factors, especially 
the large decrease in the percentage smokers (18;19) and serum cholesterol levels (18), and the 
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Figure 1.1. Life expectancy at birth and age 50 among men from 1960 through 2007 (Source: CBS Statline).
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improvement in treatment (19), are responsible for the remarkable decrease in CVD and CHD 
mortality in the Netherlands in the past 30 years (figure 1.2). 
About 50% of coronary heart disease deaths are sudden. Sudden cardiac death is defined 
as a natural, nonviolent, unexpected death due to cardiac causes, and occurring within one 
hour of the onset of acute symptoms (20). A sub-classification to distinguish ‘coronary’ from 
‘noncoronary’ sudden cardiac deaths has been proposed. The time until death after onset of 
symptoms was originally 24 hours but has been set to one hour or even an instantaneous event 
to account for a more likely arrhythmic mechanism (21;22). As a consequence, definitions of 
sudden cardiac death may vary between studies. In most cases of sudden cardiac death, the 
underlying mechanism is ventricular fibrillation caused by coronary atherosclerosis (21;22). 
The risk of sudden cardiac death is the highest within 6 to 18 months after a primary cardiac 
event; thereafter, the risk decreases (23). In general, risk factors for sudden cardiac death seem 
the same as those for atherosclerotic coronary disease (22), but need further study.
Lifestyle factors, cardiovascular mortality and life expectancy
Smoking habits and alcohol consumption are major risk factors for cardiovascular diseases and 
strong determinants of life expectancy.
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Smoking habits
Smoking has been recognized as a major health hazard for many years. Smoking causes a wide 
range of diseases including CVD, cancer, and chronic obstructive pulmonary diseases (COPD). 
Smoking cessation has impressive health benefits (24-26). Cigarette smoking cessation 
decreases the risk of chronic diseases, but stopping smoking at age 50 increases life expectancy 
with about 6 years. Even stopping at age 60 gains about 3 years of life expectancy (27).
 Since smoking habits change during life, information on long-term smoking history is 
therefore required to get correct estimates of the long-term health effects of smoking. Because 
in most studies the level of detail on smoking history is limited, the impact of various aspects of 
the smoking history remains unclear. Leffondré et al. (28) show the importance of information 
on smoking duration, intensity and time since cessation in this respect. Although smoking 
duration has been associated with mortality in earlier studies, the majority focused on cancer 
mortality rather than on CVD and COPD mortality (29-35). Moreover, little is known about the 
adverse health effects of long-term cigar or pipe smoking (36-38).
Alcohol consumption
Results of prospective studies show a U- or J-shaped relationship between alcohol intake and 
all-cause mortality (39). This association can be explained by a lower risk of CVD mortality in 
light to moderate drinkers compared to heavy drinkers and abstainers (40-43). The protective 
effect of light to moderate alcohol intake may be due to an increase in HDL cholesterol 
and prevention of blood clotting and reduction of platelet aggregation (44;45). Red wine 
consumption may have an additional health benefit because of its polyphenolic compounds 
(46;47) that interfere with the initiation, progression and rupture of atherosclerotic plaques 
(48), and improve endothelial function (49;50). Although some epidemiological studies 
showed beneficial effects of wine consumption (51;52), results of several other studies do not 
show an advantage of one type of alcoholic beverage over another (53). The effects of long-
term amount of alcohol intake and type of alcoholic beverage on cardiovascular mortality and 
life expectancy need further study.
Diet and (sudden) coronary mortality
According to the classic diet-heart hypothesis, the consumption of saturated fatty acids and 
dietary cholesterol raises plasma (LDL) cholesterol levels, thereby causing coronary heart 
disease (54). However, more recent studies have shown that the increased risk of CHD is not only 
due to an increase in (LDL) cholesterol levels but also to other factors like inflammation (55-
57) (figure 1.3). Moreover, the intake of other dietary factors, among which trans unsaturated 
fatty acids, n-3 fatty acids, and dietary fiber (8), may influence the risk of CHD (figure 1.3).
Trans unsaturated fatty acids
Results from several studies suggest that trans unsaturated fatty acids are strongly associated 
with the risk of CHD. This is consistent with findings from clinical trials showing that these 
fatty acids increase LDL cholesterol and lower HDL cholesterol concentrations in blood (58) 
and negatively affect other risk factors such as inflammation and endothelial function (59). In 
prospective studies, each 2% increase in energy intake from trans unsaturated fatty acids was 
13
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associated with a 23% increase in the incidence of CHD (60). However, little is known about 
the effects of trans unsaturated fatty acid intake on sudden coronary death.
Fish consumption
In contrast to the adverse effects of trans unsaturated fatty acids, consuming a relatively small 
amount of fish or fish oil was associated with a lower risk of CHD death (61-65). Eicosapentaenoic 
acid (C20:5n-3, EPA) and docosahexaenoic acid (C22:6n-3, DHA), two very long-chain n-3 
polyunsaturated fatty acids mainly found in fatty fish, are the constituents in fish oil that may 
reduce the risk of CHD death. The most likely explanation by which relatively small amounts 
of EPA and DHA reduce the risk of CHD death are their anti-arrhythmic properties (66). In a 
meta-analysis of cohort studies, He et al. estimated that consuming fish once a week lowers 
CHD death risk by 15% (65). In addition, Mozaffarian and Rimm estimated, by combining 
results from both randomized trials and large prospective cohort studies, that consuming 250 
mg EPA+DHA per day lowers CHD death risk by 36% (64;67). Moreover, long-chain n-3 
fatty acids are also suggestive for an inverse relation with sudden cardiac death (68;69). In 
observational studies, consuming fish once or twice a week was associated with a 42-50% 
lower risk of sudden cardiac death or cardiac arrest (70-72). The associations with blood or cell 
membrane (71) levels of EPA+DHA were even stronger. More research is needed on the effect 
of long-term fish consumption or EPA+DHA intake on (sudden) coronary deaths. 
Dietary fiber intake
Epidemiological studies have shown that consumption of (whole grain) cereals (73-76), 
vegetables and fruit (77-80) may lower the risk of CHD mortality. Dietary fiber is one of the 
components that may be responsible for the beneficial effects of these foods. Results from 
intervention trials have shown that (water-soluble) dietary fiber may lower blood cholesterol 
levels (81), reduce blood pressure (82;83), promote body weight loss (84) and may improve 
insulin sensitivity (85), and thereby lower the risk of CHD mortality (86-89). In a pooled 
analysis of cohort studies, total dietary fiber intake was inversely associated with the risk 
n-3 Fatty acids
Saturated fatty acids
Trans unsaturated fatty acids
Other specified fats
Carbohydrate type and quality
Nuts, legumes, fruits and 
vegetables
Micronutrients
Food processing
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Acute plaque rupture
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Congestive heart failure
Atrial fibrillation
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Cognitive decline
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Blood pressure levels
Modifying
factors
Modifying
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Figure 1.3. Effects of dietary factors on intermediate risk factors and cardiovascular outcomes (adapted from 
reference 67).
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of CHD mortality (86). Furthermore, the intake of dietary fiber from cereals and fruits was, 
independent of each other, inversely associated with the risk of CHD mortality (86). However, 
the effects of long-term dietary fiber intake on coronary and all-cause mortality need further 
investigation.
Long-term exposure
Lifestyle habits and food consumption patterns usually change during the course of life and 
may affect the diet-disease relationship. However, in prospective cohort studies, information on 
lifestyle factors and food consumption is generally only assessed at the baseline examination, 
assuming that these habits are relatively constant over the entire study period. Repeated 
measures of lifestyle factors and food consumption over a longer period of time can take into 
account changes in these habits. Moreover, the use of repeated measures, especially an average 
exposure, reduces measurement error due to a reduction in within-subject variation over time 
(90). Furthermore, the use of repeated measures can give more insight into the etiology of 
diseases. An average or long-term exposure may be etiologically more relevant than baseline 
or most recent exposure (90;91). 
Rationale and outline of the thesis
The main objective of this thesis is to assess the relationships of recent and long-term exposure 
to known lifestyle and dietary risk factors with cardiovascular mortality and life expectancy. 
For this purpose, we used data from the Zutphen Study, a prospective cohort study among men 
born between 1900 and 1920 and residing for at least 5 years in Zutphen, The Netherlands. 
These men were examined repeatedly between 1960 and 2000. We used up to seven repeated 
measures of lifestyle factors and dietary habits to take into account changes in these habits 
during the follow-up period, and to reduce measurement error. Moreover, we used the repeated 
measures to assess whether an average or long-term exposure is more important than a recent 
exposure in the etiology of cardiovascular and all-cause mortality. 
 In epidemiological studies, hazard ratios are commonly used to express the impact on 
mortality. Since hazard ratios express effects for an exposed group relative to the effect of 
the unexposed group, they do not provide information regarding absolute health effects. Such 
insight can be obtained by the calculation of life expectancies and the number of life-years lost. 
Although concepts like life expectancy are more informative and easier to understand, they are 
not reported frequently. Therefore, we present our results also in terms of differences in life 
expectancy at age 50 in addition to hazard ratios.
 We describe the relationships of long-term cigarette, cigar or pipe smoking, and duration 
and the number of cigarettes smoked, with cardiovascular mortality and life expectancy in 
chapter 2. The impact of long-term alcohol intake and different types of alcoholic beverages 
consumed on cardiovascular mortality and life expectancy is estimated in chapter 3. Chapter 4 
describes the changes in trans unsaturated fatty acid intake between 1960 and 2000. Moreover, 
we relate long-term trans unsaturated fatty acid intake (chapter 4) and fish consumption or 
EPA+DHA intake (chapter 5) to (sudden) coronary mortality. In chapter 6, the impact of recent 
and long-term dietary fiber intake on coronary and all-cause mortality is described. Finally, the 
15
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main findings, methodological considerations, public health implications, and suggestions for 
future research are discussed in chapter 7.
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Abstract
Study objective: To study the effect of long-term smoking on all-cause and cause-specific 
mortality, and to estimate the effects of cigarette and cigar or pipe smoking on life expectancy.
Design: A long-term prospective cohort study.
Setting: Zutphen, The Netherlands.
Participants: 1373 men from the Zutphen Study, born between 1900 and 1920 and studied 
between 1960 and 2000.
Measurements: Hazard ratios for type of smoking, amount and duration of cigarette smoking, 
obtained from a time-dependent Cox regression model. Absolute health effects of smoking are 
expressed as differences in life expectancy and the number of disease-free years of life.
Main results: Duration of cigarette smoking was strongly associated with mortality from 
cardiovascular diseases, lung cancer and chronic obstructive pulmonary disease, whereas 
both the number of cigarettes smoked as well as duration of cigarette smoking were strongly 
associated with all-cause mortality. Average cigarette smoking reduced the total life expectancy 
by 6.8 years, whereas heavy cigarette smoking reduced the total life expectancy by 8.8 years. 
The number of total life-years lost due to cigar or pipe smoking was 4.7 years. Moreover, 
cigarette smoking reduced the number of disease-free life-years by 5.8 years, and cigar or pipe 
smoking by 5.2 years. Stopping cigarette smoking at age 40 increased the life expectancy by 
4.6 years, while the number of disease-free life-years was increased by 3.0 years. 
Conclusions: Cigar or pipe smoking reduces life expectancy to a lesser extent than cigarette 
smoking. Both the number of cigarettes smoked and duration of smoking are strongly associated 
with mortality risk and the number of life-years lost. Stopping smoking after age 40 has major 
health benefits.
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Introduction
Smoking has been recognized as a health hazard for many years. Smoking causes a wide range 
of diseases including cancer, chronic obstructive pulmonary disease (COPD) and cardiovascular 
diseases (CVD), and smoking cessation has impressive health benefits (1-3). Cigarette smoking 
cessation decreases the risk of diseases and also increases life expectancy. Even stopping at age 
60 gains about 3 years of life expectancy (4). Much less is known about the adverse effects of 
long-term cigar or pipe smoking (5-7). 
 Smoking has both long- and short-term effects. As smoking habits change during life, 
information on long-term smoking history is required to obtain correct estimates of the long-
term health effects of smoking. Because in most studies the level of detail on smoking history is 
limited, the impact of various aspects of the smoking history remains unclear. Leffondré et al. 
(8) show the importance of information on smoking duration, intensity and time since cessation 
in this respect. Although smoking duration has been associated with mortality before, most 
studies focused on cancer mortality rather than CVD and COPD mortality (9-15).
 In epidemiological studies, hazard ratios are commonly used to express the impact on 
mortality. Hazard ratios express effects for one exposure group relative to the effect of the 
unexposed group –that is, the reference group– but do not give information regarding absolute 
public health effects. Therefore, life expectancies should be calculated. Although concepts 
like life expectancy are more informative and readily grasped by all, they are not reported 
frequently.
 The objective of this study is to asses the relationships between long-term cigarette, cigar 
or pipe smoking, and duration and the number of cigarettes smoked, and mortality. To obtain 
accurate effect estimates, we used repeated measures of smoking habits collected in a 40-year 
period and adjusted for potential confounders. In addition to hazard ratios, we present our 
results also in terms of changes in life expectancy at age 40 and the number of disease-free 
years of life due to cigarette and cigar or pipe smoking.
Materials and methods
Study population
The Zutphen Study was started as the Dutch contribution to the Seven Countries Study, a 
longitudinal study of the relationships between diet, other risk factors and chronic diseases 
(16). The Zutphen Study has been carried out since 1960 among middle-aged men in Zutphen, 
an old industrial town in the eastern part of the Netherlands with about 25 000 inhabitants. In 
1960, a random sample was drawn of 1088 men born between 1900 and 1919 and residing for 
at least 5 years in Zutphen. Of these, 878 (81%) men participated in the Zutphen Study and 872 
men took part in both dietary and medical examinations. The examinations were repeated in 
1965, 1970, 1985, 1990, 1995 and 2000. In 1985, the group of 554 survivors was extended with 
a new random sample of men of the same age. Of the 1266 men who were invited, 939 (74%) 
men participated and 825 (65%) men took part in both dietary and medical examinations. These 
examinations were repeated in 1990, 1995 and 2000. 
 Baseline data was collected in 1960 before the Helsinki Declaration was developed, and 
oral informed consent was obtained in view of follow-up data. In 1985 and 1990, the study 
was approved by the Medical Ethics Committee of the University of Leiden, The Netherlands, 
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and in 1995 and 2000, by the Medical Ethics Committee of the Netherlands Organisation for 
Applied Scientific Research (TNO). 
Assessment of smoking habits
Information on smoking habits was collected using standardized questionnaires. From 1960 
until 1990 detailed information was gathered on type and amount of smoking (cigarette, cigar 
and pipe). The 1995 and 2000 questionnaires combined cigar and pipe smoking, and participants 
were asked whether they still smoked and how much they smoked per day. In 1960 and 1985, 
information on the age at smoking initiation and, in case of former smokers, age at cessation 
was collected for cigarette smoking. Duration of cigarette smoking was calculated using 
information on duration of smoking at baseline and information on smoking in the following 
measurement years. In addition, we calculated time until death or censoring since smoking 
cessation. As the number of men who smoked a pipe was small, men who smoked cigar, pipe 
or both were considered as one group. Additionally, we created an overall smoking variable, 
combining cigarette and cigar or pipe smoking. The present study has a relatively small sample 
size and the number of never smokers is very small. Consequently, for cigarette, cigar or pipe 
and overall smoking, men were divided into categories of never or long-term ex-smokers –that 
is, stopped smoking >10 years ago, recent ex-smokers –that is, stopped smoking <10 years ago, 
and current smokers. At the start of this study, the number of current smokers was very high and 
decreased remarkably during 40 years of follow-up. As similar trends in smoking habits were 
seen in the general Dutch population, the information on smoking habits was considered valid.
Assessment of potential confounders
Information on food consumption was collected using the cross-check dietary history method, 
adapted to the Dutch situation (17;18). Energy and alcohol intake was calculated using food 
composition tables close to the year of measurement. The participants were divided into two 
groups according to alcohol use (yes or no). Alcohol use was defined as having at least 1 g of 
alcohol intake per day, which is equivalent to about one alcoholic beverage per week.
 During medical examinations, the weight and height of men were measured and body mass 
index (BMI) was calculated (kg/m2). Information about the prevalence and history of myocardial 
infarction (MI), stroke, diabetes mellitus (DM) and cancer was collected throughout the study. 
The men were classified into four levels of socioeconomic status (manual workers, non-manual 
workers, small business owners and professionals) according to occupation at baseline. 
Case assessment
Participants were followed until death, or censoring on 30 June 2000. During the study, six 
participants were lost to follow-up and were censored after their last physical examination. The 
final causes of death were ascertained by one clinical epidemiologist and coded according to 
the International Classification of Diseases, Eighth Revision (codes 410.0-414.9 for coronary 
heart disease, codes 390.0-459.9 for CVD, codes 140.0-208.9 for cancer, codes 162.0-162.9 for 
lung cancer and codes 490.0-492.9 and 496 for COPD). Because the underlying cause of death 
in elderly people is often difficult to ascertain, we included primary, secondary and tertiary 
causes of death in our analyses.
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Statistical analysis
Cox proportional hazard analyses were performed with age as the time variable, with smoking 
information updated at each measurement round. In addition, we modelled the effects of 
duration of cigarette smoking (per 10 years), the number of cigarettes smoked (per 10 cigarettes 
per day) and time since cigarette smoking cessation (per 5 years) both separately as well as 
combined (8). As many smokers quit at the time of serious illness, the number of cigarettes 
smoked was adjusted for ever smoking (yes or no). The duration of smoking and the time since 
cigarette smoking cessation were adjusted for age at initiation.
 We determined differences in life expectancies at age 40 and the number of disease-free 
years of life between current smokers and never or long-term ex-smokers, by calculating the 
area under survival curves. For disease-free years of life, survival until the age of onset of 
either MI, stroke, DM or cancer was used. Smokers who stopped smoking during follow-
up were excluded from the analyses from the moment they stopped, and men who started 
smoking during follow-up were included in the analyses from the moment they started. The 
differences in life expectancy and the number of disease-free years of life due to cigar or 
pipe smoking were studied among men who were never or long-term ex-cigarette smokers. In 
addition, we calculated differences in life expectancy and the number of disease-free years of 
life for different ages at cigarette smoking cessation (age 40, 50, 60 or 70 years) compared with 
continuing smoking at that age and for every 10 cigarettes per day increase. A Cox proportional 
hazard model, with age as the time variable, was used to obtain the survival curves, adjusted 
for baseline covariates. For those men who started the study in 1960, values in 1960 were used 
as baseline values, whereas, for those men who started the study in 1985, values in 1985 were 
used as baseline values. 95% CIs were obtained using the bootstrap method (19). 
 For Cox proportional hazard models, the PHREG procedure of SAS/STAT software 
V.9.1 was used. The covariates in multivariate models included energy intake (kcal/day), 
use of alcohol (yes/no), BMI (kg/m2) and baseline socioeconomic status (manual workers, 
non-manual workers, small business owners and professionals), and were updated at each 
measurement round. We adjusted for the prevalence of MI (yes/no), stroke (yes/no), DM (yes/
no) and cancer (yes/no), updating this information at each measurement round, to account for 
the possibility that smokers quit smoking because of serious illness. Furthermore, cigarette 
smoking was adjusted for cigar or pipe smoking. All available data was used for the analysis. 
Results
Table 2.1 shows the major characteristics of the men participating in the Zutphen Study during 
40 years of follow-up (mean follow-up of all participants: 28 years). During follow-up, 1130 
of the 1373 men died: CVD was the primary cause of death in 36% of all deaths, and coronary 
heart disease in 20% of all deaths. Total cancer, lung cancer and COPD were the primary cause 
in respectively, 26%, 10% and 4% of all deaths. Of the men who were included in the study 
in 1960, 74% smoked cigarettes in 1960. Among those men who were still alive in 2000, 12% 
were current cigarettes smokers (figure 2.1A). The percentage of current smokers was lower 
among the men who were newly included in 1985. Moreover, the current smokers in 1960 had 
an average cigarette smoking duration of 17 years during 40 years of follow-up. For the current 
smokers in 1985, this figure was 7 years. Among smokers, the number of cigarettes smoked per 
day decreased from 13 to 3 cigarettes in the period 1960-2000. 
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Figure 2.1. Changes in cigarette (A) and exclusive cigar or pipe (B) smoking within the Zutphen Study, during 40 
years of follow-up. Changes in exclusive cigar or pipe smoking were studied among those men who were never or 
long-term ex-cigarette smokers. Recent ex-smokers are defined as men who stopped smoking <10 years ago. Never 
and long-term ex-smokers are defined as men who never smoked or stopped smoking >10 years ago.
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In 1960, the percentage of cigar or pipe smoker among those men who were never or long-term 
ex-cigarette smokers was 54% (figure 2.1B). These exclusive cigar or pipe smokers smoked, 
on average, three cigars and six pipes per day. Again, the percentage of exclusive cigar or pipe 
smokers was lower among men who were newly included in 1985. The percentage of alcohol 
users doubled from 36% in 1960 to 75% in the period 1985-2000. Average energy intake, 
without alcohol, decreased substantially from 3082 to 1992 kcal/day. Average BMI increased 
from 24.1 kg/m2 in 1960 to 26.0 kg/m2 in 2000. 
 Using updated information at each measurement round and after adjustment for potential 
confounders, smoking was strongly associated with all-cause and cause-specific mortality 
(table 2.2). Hazard ratios (HR) for current cigarette smoking varied between 1.40 (95% CI: 
1.07 to 1.83) for cancer mortality and 2.90 (1.80 to 4.68) for COPD mortality. The associations 
between recent ex-smoking and mortality were weaker, and varied between 1.15 (0.84 to 
1.57) and 2.98 (1.78 to 5.01) for cancer and COPD mortality, respectively. In general, the 
associations between smoking and mortality were stronger for overall smoking compared 
with cigarette smoking. Furthermore, for cardiovascular mortality we found a significant and 
inverse interaction between smoking status and survival age. This indicates that the association 
between smoking status and cardiovascular mortality weakens with a higher survival age.
 Every 10-year increase in cigarette smoking duration was strongly associated with 
mortality from all-causes (HR: 1.12), CVD (HR: 1.15), lung cancer (HR at mean survival 
age: 1.31) and COPD (HR: 1.38), independent of the number of cigarettes smoked 
(table 2.3). In addition, every 10 cigarettes per day increase was associated with all-cause 
mortality (HR: 1.11), independent of smoking duration (table 2.3). When studying the 
association between duration of cigarette smoking and lung cancer mortality, we found 
a significant and inverse interaction with survival age. This indicates that the association 
between duration of cigarette smoking and mortality weakens with a higher survival age. 
 Moreover, omitting the adjustment for the prevalence of chronic diseases attenuated our 
results slightly but the overall conclusions remained the same, except for cancer mortality. 
For total cancer mortality, the HR for every 10 cigarettes per day increase increased from 1.14 
(0.97 to 1.32) to 1.24 (1.06 to 1.43) and the HR for every 10-year increase in cigarette smoking 
duration increased from 1.07 (0.96 to 1.19) to 1.11 (1.01 to 1.22), whereas for lung cancer 
mortality these HR changed from 1.14 (0.90 to 1.44) to 1.32 (1.11 to 1.58) and from 1.31 (1.07 
to 1.60) to 1.25 (1.06 to 1.47), respectively. As duration of smoking and time since cessation 
were strongly and inversely correlated (Rho <-0.78), we were not able to include both in the 
same model. The separate associations of time since cigarette smoking cessation with mortality 
were opposite to the association for smoking duration (data not shown). Age at initiation of 
cigarette smoking did not independently contribute to mortality risk and was therefore left out 
of the models.
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Table 2.3. Modelling cigarette smoking history in relation to mortality1 within the Zutphen 
Study, according to updated covariates at each measurement round 
 Crude HR 
(95% CI)2 
Adjusted HR 
(95% CI)3 
Adjusted HR 
(95% CI)4 
All cause 
No of cigarettes  
smoked (per 10 cigarettes/ day) 
1.22 (1.13 to 1.32) 1.10 (1.00 to 1.20) 1.11 (1.01 to 1.21) 
Duration (per 10 years) 1.11 (1.08 to 1.14) 1.13 (1.07 to 1.18) 1.12 (1.06 to 1.18) 
Total cardiovascular  
No of cigarettes  
smoked (per 10 cigarettes/ day) 
1.11 (1.00 to 1.24) 0.99 (0.88 to 1.13) 1.06 (0.93 to 1.20) 
Duration (per 10 years) 1.09 (1.04 to 1.13) 1.13 (1.06 to 1.21) 1.15 (1.07 to 1.23) 
Coronary heart disease 
No of cigarettes 
smoked (per 10 cigarettes/ day) 
1.12 (0.97 to 1.30) 1.05 (0.88 to 1.25) 1.17 (0.98 to 1.39) 
Duration (per 10 years) 1.07 (1.01 to 1.14) 1.08 (0.98 to 1.20) 1.10 (1.00 to 1.21) 
Total cancer 
No of cigarettes  
smoked (per 10 cigarettes/ day) 
1.36 (1.20 to 1.54) 1.25 (1.08 to 1.45) 1.14 (0.97 to 1.32) 
Duration (per 10 years) 1.17 (1.10 to 1.24) 1.12 (1.02 to 1.22) 1.07 (0.96 to 1.19) 
Lung cancer 
No of cigarettes  
smoked (per 10 cigarettes/ day) 
1.65 (1.38 to 1.98) 1.36 (1.10 to 1.70) 1.14 (0.90 to 1.44) 
Duration (per 10 years) 1.42 (1.26 to 1.61) 1.29 (1.09 to 1.52) 1.31 (1.07 to 1.60)5 
COPD 
No of cigarettes  
smoked (per 10 cigarettes/ day) 
1.18 (0.95 to 1.48) 0.81 (0.62 to 1.07) 0.99 (0.73 to 1.33)5 
Duration (per 10 years)  1.34 (1.20 to 1.49) 1.51 (1.28 to 1.78) 1.38 (1.17 to 1.63) 
COPD, chronic obstructive pulmonary disease; 1Because of missing data, the number of events may be smaller than 
the number mentioned in table 2.1; 2Crude HR, hazard ratio for separate models for duration and the number of 
cigarettes (adjusted for ever smoking (yes/no)); 3HR for multivariate models including duration of cigarette smoking 
and the number of cigarettes smoked, adjusted for ever smoking; 4HR for multivariate models with additional 
adjustment for cigar or pipe smoking, energy intake, alcohol use, body mass index, baseline socioeconomic status 
and the prevalence of myocardial infarction, stroke, diabetes mellitus and cancer; 5Hazard ratios were calculated 
using mean survival age (76 years). 
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Figure 2.2 shows the adjusted survival curve used for determining the life expectancies at age 
40. Current cigarette smoking reduced life expectancy by 6.8 years and the number of disease-
free life years-that is, years free from MI, stroke, DM and cancer-by 5.8 years. For current 
overall smoking, the adjusted difference in life expectancy between smokers and never or long-
term ex-smokers was comparable to cigarette smoking (table 2.4). Among the exclusive cigar 
or pipe smokers, life expectancy was reduced by 4.7 (1.5 to 8.0) years and the number of 
disease-free years of life by 3.7 (-1.7 to 9.1) years. After adjustment for potential confounders, 
the total number of life-years lost due to cigar or pipe smoking was 4.7 (1.4 to 8.0) years and 
the number of disease-free life-years lost was 5.2 (-1.5 to 12.0) years. In addition, the number 
of total and disease-free years of life lost increased when more cigarettes were smoked (table 
2.4). The adjusted number of total life-years lost ranged from 2.1 for men who smoked 11-
00.2
0.4
0.6
0.8
1
40 50 60 70 80 90 100
Age (years)
Su
rv
iv
a
l r
a
te
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Never and long-term ex-
smokers
Cigarette smokers
Figure 2.2. Survival curves for cigarette smokers and never and long-term ex-smokers within the Zutphen Study, 
adjusted for baseline energy intake, alcohol use, body mass index, prevalence of myocardial infarction, stroke, 
diabetes mellitus and cancer, socioeconomic status, and cigar or pipe smoking. 
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20 cigarettes per day to 8.8 years for men who smoked >30 cigarettes per day, whereas the 
number of disease-free life-years lost ranged from 2.1 years to about 10.6 years. Men who 
stopped smoking at age 40 gained 4.6 life-years, compared with men who continued smoking 
at that age (table 2.4), while the gained life-years were 2.5-3.3 years among men who stopped 
smoking at age 50, 60 or 70 years. The number of disease-free years of life gained by stopping 
smoking after age 40 were less compared with the total number of life-years gained, but still 
0.3-3.0 years.
Discussion
Our results clearly show the importance of amount, duration and type of smoking in the relation 
to mortality. Average cigarette smoking reduced life expectancy at age 40 by about 7 years and 
heavy cigarette smoking reduced life expectancy even more. The average cigar or pipe smoker 
lost about 5 life-years. Smoking decrease total life expectancy, and also decreased the number 
of disease-free years of life, but to a smaller extent. Moreover, stopping cigarette smoking at 
age 40 increased the total life expectancy by about 5 years and the number of disease-free years 
of life by about 3 years. 
 The major strength of this study was the collection of detailed information on smoking 
habits at each of seven examination rounds during 40 years of follow-up. This enabled us 
to study long-term effects of cigarette as well as cigar or pipe smoking on mortality and life 
expectancy. Moreover, detailed data on potential confounders made it possible to study the 
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independent effect of smoking. Adjustment for potential confounders reduced the number of 
life-years lost by half a year.
 This study also has weaknesses. Firstly, the Zutphen Study had a relatively small study 
population which may have led to less precise results. Secondly, the number of never smokers 
was also very small, and we were therefore forced to combine men who stopped smoking for 
>10 years with men who never smoked in our reference group. Because studies have suggested 
that mortality risk after 10 years of smoking cessation is comparable to that of in never-smokers 
(2;20), we used this cut-off value. However, more recent studies showed that mortality risk 
is comparable to that in never-smokers only after 10-15 (21-24) or more (24-26) years of 
cessation and so the differences in life expectancy may have been underestimated. Thirdly, the 
Zutphen Study started in 1960 with 872 men. The cohort of men who survived until 1985 was 
expanded with an additional cohort of 559 men. However, since this additional cohort of men 
was from the same birth cohort as the men who started the study in 1960, it is unlikely that bias 
was introduced.
 Our findings confirmed results from others that also showed an increase in all-cause mortality 
risk with cigarette smoking duration and the number of cigarettes smoked (9;13-15;20;23;27-
30). After the adjustment for the prevalence of MI, stroke, DM and cancer, only cigarette 
smoking duration was associated with lung cancer mortality. By omitting this adjustment for 
chronic disease prevalence, both smoking duration as well as the number of cigarette smoked 
were found to be strongly associated with total cancer and lung cancer mortality. This result 
confirms those from other studies (9-11;15;20;28-30). In addition, we confirmed the results of 
other studies which showed dose-response relationships between smoking duration and COPD 
mortality (9;15).
 In accordance with other studies (6;7), the effects of cigar or pipe smoking on mortality 
were weaker compared to the effects of cigarette smoking. To our knowledge, we are the first 
to reported on the effects of exclusive cigar or pipe smoking on life expectancy. This study 
found that the effects on life expectancy observed for cigar or pipe smoking were close to those 
observed for cigarette smoking. Exclusive cigar or pipe smoking reduced life expectancy by 
about 5 years, whereas cigarette smoking reduced life expectancy by about 7 years. 
 In the British Doctors Study (4), the Framingham Heart Study (31) and the Cancer 
Prevention Study II (32), the reduction in life expectancy due to smoking was about 9 years. The 
difference in the reduction in life expectancy compared with this study may be due to several 
factors. Firstly, life expectancy within these studies was assessed at different ages. Secondly, 
men who stopped smoking >10 years ago were not included in the reference group. Thirdly, 
the adjustment for possible confounders was not carried out in these studies and, finally, the 
average amount smoked might have been higher compared with that in this study. Both the 
British Doctors Study (29) as well as our study found that heavy cigarette smokers lost 9-10 
life-years, indicating that the amount smoked is associated with reductions in life expectancy. 
 In accordance with the British Doctors Study (4) and the Cancer Prevention Study II (32), 
we found that smoking cessation has beneficial effects on life expectancy. These studies as well 
as this study found a substantial increase in life expectancy of about 3 years when stopping 
smoking at age 60. The main focus in smoking prevention programmes is preventing smoking 
initiation. The results from this and other studies indicate that the persuasion of smokers to quit 
smoking, even later in life, should be another important focus from a public health perspective.
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In this study, the reduction in the number of disease-free years of life due to smoking was 
comparable between the different types of smoking. Other studies also addressed the differences 
in the number of disease-free years of life (31;33;34). Although these studies defined disease-
free years of life differently from this study and did not distinguish between different types of 
smoking, the overall conclusions were similar. Never smokers and quitters live longer than 
continuing smokers, and they also spend more years of life in better health.
 In summary, cigarette and cigar or pipe smoking reduces life expectancy and the number of 
disease-free years of life. However, the number of life-years lost due to cigar or pipe smoking 
is fewer compared with cigarette smoking. Both the number of cigarettes smoked and smoking 
duration are strongly associated with mortality risk and the number of life-years lost. Although 
our results indicate that the effects will be larger the earlier one quits, even stopping at age 60 
has major benefits on life expectancy.
Conflict of interest: None.
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Abstract
Background: Light to moderate alcohol intake lowers the risk of cardiovascular mortality, but 
whether this protective effect can be attributed to a specific type of beverage remains unclear. 
Moreover, little is known about the effects of long-term alcohol intake on life expectancy.
Methods: The impact of long-term alcohol intake and types of alcoholic beverages consumed 
on cardiovascular mortality and life expectancy at age 50 was investigated in the Zutphen 
Study, a cohort of 1373 men born between 1900 and 1920, and examined repeatedly between 
1960 and 2000. Hazard ratios for total alcohol intake and alcohol from wine, beer and spirits 
were obtained from time-dependent Cox regression models. Life expectancy at age 50 was 
calculated from areas under survival curves. 
Results: Long-term light alcohol intake, i.e. <20 grams per day, compared to no alcohol, 
was strongly and inversely associated with cerebrovascular (HR: 0.43 [0.26 to 0.70]), total 
cardiovascular (HR: 0.70 [0.55 to 0.89]) and all-cause mortality (HR: 0.75 [0.63 to 0.91]). 
Independent of total alcohol intake, long-term wine consumption of, on average, less than half 
a glass per day was strongly and inversely associated with coronary heart disease (HR: 0.61 
[0.41 to 0.89]), total cardiovascular (HR: 0.68 [0.53 to 0.86]) and all-cause mortality (HR: 0.73 
[0.62 to 0.87]). These results could not be explained by differences in socioeconomic status. 
Life expectancy was about 5 years longer in men who consumed wine compared to those who 
did not use alcoholic beverages.
Conclusion: Long-term light alcohol intake lowered cardiovascular and all-cause mortality 
risk, and increased life expectancy. Light wine consumption was associated with a 5 years 
longer life expectancy; however, more studies are needed to verify this result. 
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Introduction
Many studies have demonstrated a U- or J-shaped relationship between alcohol intake and 
all-cause mortality. This association can be explained by a lower risk of cardiovascular disease 
(CVD) mortality in light to moderate drinkers (1-4). The protective effect of light to moderate 
alcohol intake may be due to an increase in HDL cholesterol and prevention of blood clotting 
and reduction of platelet aggregation (5;6). Red wine consumption may have an additional 
health benefit because of its polyphenolic compounds (7;8) that interfere with the initiation, 
progression and rupture of atherosclerotic plaques (9), and improve endothelial function (10;11). 
Although some epidemiological studies showed beneficial effects of wine consumption (12;13), 
results of several other studies do not show an advantage of one type of alcoholic beverage over 
another (14). Studies have suggested that the beneficial effects of wine consumption compared 
to other beverages can mainly be attributed to differences in socioeconomic status, dietary and 
other lifestyle habits (15;16).
 In prospective cohort studies in which alcohol intake is only assessed at the baseline 
examination, consumption patterns are assumed to be relatively constant over the entire study 
period. However, it is unlikely that exposure measurements in the past accurately reflect long-
term alcohol intake since consumption patterns usually change during life. To get correct 
estimates of long-term effects of alcohol intake, repeated measures are needed. Moreover, the 
use of repeated measures, especially when using a cumulative average method, reduces within-
subject variation over time and, thereby, misclassification in alcohol intake (17).
 In epidemiological studies, hazard ratios are commonly used to express the impact on 
mortality. Since hazard ratios express effects for an exposed group relative to the effect of 
the unexposed group, they do not provide information regarding absolute health effects. Such 
insight can be obtained by the calculation of life expectancies and the number of life-years lost. 
Although concepts like life expectancy are more informative and easier to understand, they are 
not reported frequently.
 The objective of the present study is to assess the relationship between long-term intake 
of alcohol and the types of alcoholic beverages consumed, and cardiovascular and all-cause 
mortality. To obtain more accurate effect estimates, we used seven repeated measures of the 
consumption of alcoholic beverages. In addition to hazard ratios, we present our results also in 
terms of differences in life expectancy. 
Methods
Study population
The Zutphen Study has been carried out since 1960 among middle-aged men in Zutphen, an 
old industrial town in the eastern part of the Netherlands with about 30 000 inhabitants. In 
1960, a random sample was drawn of 1088 men born between 1900 and 1919 and residing for 
at least 5 years in Zutphen. Of those men, 878 participated in the Zutphen Study (response rate: 
81%). Examinations were repeated in 1965, 1970, 1985, 1990, 1995 and 2000. In 1985, the 
group of 554 survivors was extended with a new random sample of men of the same age. Of 
the 1266 men who were invited in 1985, 939 men participated (response rate: 74%). In every 
examination round, the participants that took part in both the dietary and physical examinations 
were selected for the present study (1373 men). 
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Baseline data were collected in 1960 before the Helsinki Declaration was developed and oral 
informed consent was obtained in view of follow-up data. In 1985 and 1990, the study was 
approved by the Medical Ethics Committee of the University of Leiden, The Netherlands, 
and in 1995 and 2000, by the Medical Ethics Committee of the Netherlands Organisation for 
Applied Scientific Research (TNO). 
Assessment of alcohol and food consumption
The habitual alcohol consumption was assessed as part of the total diet, using the cross-check 
dietary history method (18), adapted to the Dutch situation (19;20). This method provides 
information about the participant’s usual food and alcohol consumption pattern, 6 to 12 months 
preceding the interview. From 1985 onwards, the information about the usual food and alcohol 
consumption pattern was limited to the month preceding the interview because consumption 
patterns from 1985 were much more complicated than those in the 1960s. The daily intake 
of alcohol, energy and other nutrients was calculated using food composition tables close to 
the year of measurement (21-23). Alcohol intake was highly reproducible (r=0.8) (24) and 
ranking of the participants was considered valid as shown by the strong correlation with HDL 
cholesterol (25).
 To assess the relationship between different types of alcoholic beverages and mortality, 
we calculated the alcohol intake from wine, beer or spirits, respectively. Participants were 
grouped into three categories according to their intake of total alcohol and of alcohol from beer, 
wine or spirits: 0, >0-20, and >20 g/d. Since studies have suggested that using non-drinkers 
as a reference group is unsuitable for studying the effects of alcohol on mortality because of 
the higher background risk among the former drinkers (26-28), we created a time-dependent 
indicator variable for those men who stopped drinking during follow-up. 
Assessment of potential confounders
Detailed information on type and amount of smoking was collected using standardized 
questionnaires. Cigarette, cigar or pipe smokers were divided into categories of never or long-
term ex-smokers, i.e. stopped smoking >10 years ago, recent ex-smokers, i.e. stopped smoking 
<10 years ago, and current smokers. Also, the number of years of cigarette smoking was 
calculated. During physical examinations men’s weight and height were measured and body 
mass index (BMI) was calculated. Information about the prevalence and history of clinical 
myocardial infarction (MI), stroke, diabetes mellitus (DM), and cancer was collected throughout 
the study. The men were classified into four levels of socioeconomic status (manual workers, 
non-manual workers, small business owners and professionals) according to occupation at 
baseline. 
 
Case ascertainment
Participants were followed until death, or censored on June 30, 2000. Three participants were 
lost to follow-up during the study and were censored after their last physical examination. 
Information about the causes of death was available from the official death certificate, the 
medical history collected from interviewing physicians or relatives of the dead person and other 
witnesses, and from abstracts of hospital and other medical records (29). The adjudication of the 
underlying causes of death were done by one clinical epidemiologist (Dr Alessandro Menotti, 
41
Wine, cardiovascular mortality, and life expectancy
Association for Cardiac Research, Rome, Italy) and coded according to the International 
Classification of Diseases; Eight Revision (codes 410 to 414 for coronary heart disease [CHD], 
codes 430 to 438 for cerebrovascular diseases and codes 390 to 458 for CVD) (30). Because the 
underlying cause of death in elderly people is often difficult to ascertain, we included primary 
and secondary causes of cardiovascular death.
Statistical analysis
Cox proportional hazard analyses with age as the time variable (31;32) were performed using 
the PHREG procedure of SAS/STAT software (version 9.1; SAS Institute, Inc, Cary, NC). Time 
at entry was age on December 31st of the year preceding the year the men participated in both 
the dietary and physical examinations for the first time, i.e. the first measurement round; exit 
time was age at death, age when lost to follow-up, or age when censored, whichever came first. 
We calculated the cumulative average alcohol intake to better represent long-term intake. With 
this method, exposure between 1960 and 1965 was calculated from the alcohol intake from the 
1960 examination round; exposure between 1965 and 1970 was calculated from the average 
alcohol intake from the 1960 and 1965 examination rounds, and so on (17). For those men who 
were newly included in the study in 1985, information on alcohol intake was missing in the 
period 1960-1970. To take into account that average alcohol intake was higher in 1985 than 
in 1960-1970 and that taking cumulative averages excluding earlier intakes in those men who 
were newly in the study in 1985 would overestimate their intake compared to men included 
in 1960, multiple imputation (33), five times, of alcohol intake and dietary covariates between 
1960 and 1970 was carried out with an adapted version of predicted mean matching (34). The 
SAS code that was used for the multiple imputation can be downloaded from www.rivm.nl/
sasmacros. Analyses on long-term alcohol intake were performed on five imputed datasets and 
results were pooled using the MIANALYZE procedure of SAS/STAT software.
 The covariates in the multivariable models included an indicator variable for former 
drinker, energy intake without alcohol (kcal/d), consumption of vegetables (g/d), fruit (g/d) and 
fish (g/d), intake of saturated and trans fatty acids (g/d), BMI (kg/m2), cigar or pipe smoking 
(never and long-term ex, recent-ex and current), cigarette smoking duration (divided by 10 
years), the daily number of cigarettes smoked (divided by 10), prevalence of MI (yes or no), 
stroke (yes or no), DM (yes or no), and cancer (yes or no), and indicator variables for baseline 
socioeconomic status. In additional analyses, the multivariable models for, respectively, alcohol 
from beer, wine and spirits were additionally adjusted for total alcohol intake to investigate the 
independent effects of alcohol from one specified alcoholic beverage type. In the multivariable 
analyses, the cumulative average intake of all dietary covariates was calculated and non-
dietary covariates were updated at each measurement round. To test the proportional hazards 
assumption, a product term between alcohol intake and age was included in the model, and a 
P-value for interaction <0.10 was considered statistically significant.
 We determined differences in life expectancy at age 50, i.e. average age at baseline, 
between men with different levels of cumulative average alcohol intake, by calculating the 
area under survival curves (35). To distinguish between the effects of alcohol intake and the 
effects of alcoholic beverage types, we compared the life expectancies for men who consumed 
alcohol from wine (>0 gram per day) with those who consumed alcohol from beer and spirits 
and those who consumed no alcohol from the specified sources, using cumulative average 
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intake at each measurement round. The men were included in the analysis during the period 
that they met the requirements for the exposure categories concerned. Cox models, with age 
as the time variable and stratified by categories of amount (0, >0-20, >20 g/d) or source (no 
alcohol, alcohol from wine, alcohol from beer or spirits) of alcohol intake, were used to obtain 
the survival curves. The Cox models were adjusted for baseline covariates, i.e. dietary and 
smoking variables, BMI, prevalence of chronic diseases, i.e. MI, stroke, DM and cancer, and 
socioeconomic status. Since several participants used more than one type of alcoholic beverage 
in their usual diet and are, thereby, included in different exposure categories at the same time, 
the COVSANDWICH (AGGREGATE) statement was added to the PHREG procedure. Areas 
under the survival curves from the five imputed datasets were pooled (33) and ninety-five 
percent confidence intervals were obtained using the bootstrap method (36). 
Results
Population characteristics
During 40 years of follow-up (mean survival age: 77 years), 1130 of the 1373 men participating 
in the present study died (table 3.1). Of these deaths, 628 were cardiovascular disease (CVD) 
deaths, 348 were coronary heart disease (CHD) deaths, and 139 were cerebrovascular deaths. 
 The percentage of alcohol users almost doubled from 45% in 1960 to 86% in 2000 (table 
3.1). Among users, average alcohol consumption increased from 8 g/d in 1960 to 18 g/d among 
the survivors in 1985, after which it decreased to 14 g/d in 2000 (table 3.1). The percentage of 
wine users increased remarkably from 2% in 1960 till about 40% in 2000. This increase was 
observed in all levels of socioeconomic status. Among users, the average number of glasses 
consumed varied between a half and 1.5 glasses per day for wine, beer and spirits. With the 
exception of 1960, alcohol from spirits contributed the most to the total alcohol intake (figure 
3.1). The correlation between alcohol from spirits and total alcohol intake varied between 0.67 
and 0.86. For alcohol intake from wine and beer, the correlations were lower.
Alcohol consumption, alcoholic beverages and mortality
Long-term alcohol intake was significantly and inversely associated with mortality risk (table 
3.2). Men with less than or equal to 20 grams of long-term, i.e. cumulative average, alcohol 
intake had a 57% lower cerebrovascular mortality risk, a 30% lower CVD mortality risk, and a 
25% lower all-cause mortality risk compared to men with no alcohol intake. The associations 
for more than 20 grams of long-term alcohol intake per day were weaker than those for less 
than or equal to 20 grams of long-term alcohol intake per day. 
 In the next step, the independent effects of long-term alcohol intake from wine, beer and 
spirits on mortality were estimated. After additional adjustment for total alcohol intake, less than 
or equal to 20 grams of long-term alcohol intake from wine per day –compared to no alcohol 
intake from wine– was inversely associated with CHD (HR: 0.61 [95%CI: 0.41 to 0.89]), CVD 
(HR: 0.68 [0.53 to 0.86]) and all-cause mortality risk (HR: 0.73 [0.62 to 0.87]; table 3.3). In 
the models for CVD and all-cause mortality, less than or equal to 20 grams of long-term total 
alcohol intake remained inversely associated with mortality (HR CVD mortality: 0.76 [0.59 to 
0.97]; HR all-cause mortality: 0.80 [0.67 to 0.97]). 
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Additional analyses showed that the inverse association between wine consumption and 
mortality was present in all socioeconomic classes. Among manual workers, the HRs for long-
term wine consumption were 0.63 (0.31 to 1.30) for CHD, 0.78 (0.49 to 1.23) for CVD and 
0.78 (0.54 to 1.12) for all-cause mortality. Among the professionals, the hazard ratios were 
comparable.
 Long-term consumption of alcohol from beer and spirits was not independently related to 
mortality (table 3.3). However, given the strong correlation between alcohol from spirits and 
total alcohol intake, these findings should be interpreted with caution. Omiting the adjustment 
for the prevalence of chronic diseases changed our results slightly but the overall conclusions 
remained the same.
Alcohol consumption, alcoholic beverages and life expectancy
Men with a long-term alcohol intake less than or equal to 20 grams per day (on average 6 g/d) 
had a 2.3 years (95%CI: 0.5 to 4.2 years) longer life expectancy at age 50 compared to those 
who consumed no alcohol. For those men who consumed more than 20 grams of alcohol per 
day (on average 29 g/d), life expectancy was 1.9 years (-1.1 to 4.9 years) longer compared to 
non-users.
 Men who consumed alcohol from wine, on average 2 g/d, over a longer time period had a 
2.5 years longer life expectancy at age 50 (-0.3 to 5.3 years) compared to those who consumed 
alcohol from beer or spirits (on average about 8 g/d; figure 3.2) and a 4.7 years (1.6 to 7.7 
years) longer life expectancy compared to no alcohol users. 
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Figure 3.1. The contribution of alcohol from beer, wine and spirits to total alcohol intake within the Zutphen Study 
during 40 years of follow-up.
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Discussion
Long-term light alcohol intake lowered cerebrovascular, total CVD and all-cause mortality risk, 
and was associated with a longer life expectancy compared to no alcohol intake. Independent of 
total alcohol intake, wine consumption was strongly and inversely associated with CHD, total 
CVD and all-cause mortality. For long-term wine consumers, consuming on average less than 
half a glass of wine per day, life expectancy at age 50 was about 5 years longer compared to 
no alcohol users. 
 The major strength of this study was the collection of detailed information on the 
consumption of different alcoholic beverages at each of seven examination rounds during 40 
years of follow-up. This enabled us to study the effects of long-term, i.e. cumulative average, 
alcohol intake on mortality. The use of cumulative average intakes reduces within-subject 
variation over time and, thereby, measurement error. The detailed information on potential 
confounders such as smoking (37-39), diet (40), and socioeconomic status (41) made it 
possible to study the independent effect of total alcohol intake and alcohol from different types 
of alcoholic beverages. 
 The present study also has some weaknesses. First, recent studies have observed that, 
among men, frequency of alcohol consumption was inversely associated with coronary heart 
disease risk, independent of the amount of alcohol consumed (42-44). Since in the present 
study, information on alcohol consumption was collected as part of the usual diet, no data 
was available on drinking frequency. Second, average long-term alcohol intake in the present 
study was relatively low and most participants used more than one type of alcoholic beverage 
in their usual diet. This may have led to less precise estimations of the effect of different 
types of alcoholic beverages on mortality. Third, for those men who were newly included in 
the study in 1985, information on alcohol intake was missing in the period 1960-1970. By 
multiple imputations of total alcohol intake, different types of alcoholic beverages and other 
dietary covariates in 1960-1970, we were able to counter an underestimation of cumulative 
Table 3.2. Long-term alcohol consumption in relation to cardiovascular and all-cause 
mortality within the Zutphen Study 
 Long-term intake  
(cumulative average, time-dependent) 
 
 
 
Amount Crude HR (95%CI)1 Adjusted HR (95%CI)2,3 
Coronary heart disease >0 to 20 g/d 0.92 (0.67 to 1.25) 0.80 (0.57 to 1.11) 
 >20 g/d 0.80 (0.49 to 1.31) 0.77 (0.44 to 1.33) 
Cerebrovascular >0 to 20 g/d 0.44 (0.28 to 0.68) 0.43 (0.26 to 0.70) 
 >20 g/d 0.44 (0.22 to 0.92) 0.56 (0.25 to 1.25) 
Total cardiovascular >0 to 20 g/d 0.75 (0.60 to 0.95) 0.70 (0.55 to 0.89) 
 >20 g/d 0.78 (0.56 to 1.10) 0.83 (0.56 to 1.22) 
All Cause >0 to 20 g/d 0.78 (0.65 to 0.93) 0.75 (0.63 to 0.91) 
 >20 g/d 0.82 (0.63 to 1.07) 0.82 (0.61 to 1.12) 
1Crude HR, hazard ratio CI, confidence interval; 2Hazard ratios are adjusted for former drinking, energy intake 
without alcohol, the number of cigarettes smoked, cigarette smoking duration, cigar or pipe smoking, intake of 
vegetables, fruit, fish, saturated fat and trans fatty acids, body mass index, prevalence of myocardial infarction, 
stroke, diabetes mellitus and cancer, and baseline socioeconomic status; 3Because of missing data in the covariates, 
the number of events is less than the number mentioned in table 3.1. 
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average intake from 1985 onwards for those men who were newly included in the study. We 
repeated our analysis among the participants who were included in the study from 1960 (n 
= 875) and found similar associations between long-term total alcohol intake and different 
types of alcoholic beverages, and mortality. Therefore, it is unlikely that the imputation of total 
alcohol intake, different types of alcoholic beverages and other dietary covariates among those 
men who were newly included in the study from 1985 biased our results.
 Our results confirm the inverse association between moderate alcohol intake, CVD and 
all-cause mortality risk observed in other studies (38;39;45-53). In contrast to these and other 
studies (38;39;45;53-56), the highest exposure level was not associated with an increased 
mortality risk. However, average alcohol intake in the highest exposure level was relatively low 
(29 g/d) in the Zutphen Study, which may explain the lack of a positive association between 
Table 3.3. Long-term consumption of alcohol from beer, wine or spirits in relation to 
cardiovascular and all-cause mortality within the Zutphen Study 
   Long-term intake 
(cumulative average, time-dependent) 
 Alcohol 
source 
 
Amount 
Crude HR  
(95% CI)1 
Adjusted HR  
(95% CI)2,3 
Adjusted HR  
(95% CI)3,4 
Wine >0 to 20 g/d 0.59 (0.42 to 0.83) 0.60 (0.41 to 0.87) 0.61 (0.41 to 0.89) Coronary 
heart 
disease 
 >20 g/d NI5 NI NI 
 
Beer >0 to 20 g/d 0.86 (0.68 to 1.09) 0.79 (0.62 to 1.02) 0.82 (0.60 to 1.12) 
 
 >20 g/d 1.13 (0.41 to 3.08) 1.02 (0.35 to 2.93) 1.10 (0.36 to 3.39) 
 Spirits >0 to 20 g/d 0.93 (0.70 to 1.23) 0.85 (0.63 to 1.15) 0.92 (0.63 to 1.34) 
  >20 g/d 0.86 (0.40 to 1.84) 0.89 (0.42 to 1.86) 1.01 (0.35 to 2.97) 
Wine >0 to 20 g/d 0.67 (0.44 to 1.01) 0.82 (0.53 to 1.26) 0.92 (0.58 to 1.46) Cerebro- 
vascular  
 >20 g/d NI NI NI 
 
Beer >0 to 20 g/d 0.64 (0.45 to 0.93) 0.62 (0.42 to 0.92) 0.81 (0.48 to 1.35) 
 
 >20 g/d 0.68 (0.09 to 5.01) 0.78 (0.10 to 6.26) 0.78 (0.09 to 6.73) 
 Spirits >0 to 20 g/d 0.76 (0.51 to 1.13) 0.79 (0.52 to 1.20) 1.44 (0.72 to 2.86) 
  >20 g/d 0.62 (0.19 to 1.97) 0.70 (0.21 to 2.34) 0.93 (0.20 to 4.32) 
Wine >0 to 20 g/d 0.63 (0.51 to 0.78) 0.66 (0.52 to 0.84) 0.68 (0.53 to 0.86) Total 
cardio- 
vascular 
 >20 g/d 1.37 (0.19 to 9.78) 2.45 (0.33 to 18.1) 2.20 (0.30 to 16.4) 
 
Beer >0 to 20 g/d 0.84 (0.70 to 1.00) 0.82 (0.69 to 0.99) 0.91 (0.72 to 1.14) 
  >20 g/d 1.30 (0.62 to 2.74) 1.29 (0.58 to 2.84) 1.26 (0.55 to 2.88) 
 Spirits >0 to 20 g/d 0.85 (0.69 to 1.04) 0.82 (0.66 to 1.03) 0.93 (0.70 to 1.24) 
  >20 g/d 0.84 (0.50 to 1.41) 0.91 (0.54 to 1.55) 0.88 (0.47 to 1.64) 
Table 3.3 continues on the next page. 
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Continuation of table 3.3 
   Long-term intake 
(cumulative average, time-dependent) 
 Alcohol 
source 
 
Amount 
Crude HR  
(95% CI)1 
Adjusted HR  
(95% CI)2,3 
Adjusted HR  
(95% CI)3,4 
All-cause Wine >0 to 20 g/d 0.68 (0.58 to 0.78) 0.72 (0.61 to 0.85) 0.73 (0.62 to 0.87) 
  >20 g/d 0.79 (0.11 to 5.59) 1.28 (0.18 to 9.28) 1.21 (0.17 to 8.82) 
 Beer >0 to 20 g/d 0.91 (0.80 to 1.05) 0.89 (0.78 to 1.02) 0.98 (0.83 to 1.17) 
  >20 g/d 1.41 (0.84 to 2.36) 1.29 (0.76 to 2.19) 1.37 (0.74 to 2.53) 
 Spirits >0 to 20 g/d 0.86 (0.75 to 1.00) 0.87 (0.74 to 1.01) 0.97 (0.80 to 1.18) 
  >20 g/d 1.08 (0.76 to 1.53) 1.02 (0.67 to 1.55) 1.09 (0.69 to 1.73) 
1Crude HR, hazard ratio CI, confidence interval; 2Hazard ratios are adjusted for former drinking, energy intake 
without alcohol, the number of cigarettes smoked, cigarette smoking duration, cigar or pipe smoking, intake of 
vegetables, fruit, fish, saturated and trans fatty acids, body mass index, prevalence of myocardial infarction, stroke, 
diabetes mellitus and cancer, and baseline socioeconomic status; 3Because of missing data, the number of events may 
be smaller than the number mentioned in table 3.1; 4Hazard ratios are adjusted for former drinking, energy intake 
without alcohol, the number of cigarettes smoked, cigarette smoking duration, cigar or pipe smoking, intake of 
vegetables, fruit, fish, saturated and trans fatty acids, body mass index, prevalence of myocardial infarction, stroke, 
diabetes mellitus and cancer, baseline socioeconomic status, and total alcohol intake; 5NI, because of the small 
number of men with >20 g of long-term alcohol intake from wine, the calculated hazard ratios are not informative. 
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Figure 3.2. Survival curves for men with a long-term consumption of alcohol from wine, beer or spirits, and no 
alcohol consumers within the Zutphen Study, adjusted for baseline energy intake without energy from alcohol, the 
number of cigarettes smoked, cigar or pipe smoking, intake of vegetables, fruit, fish, saturated and trans fatty acids, 
body mass index, prevalence of myocardial infarction, stroke, cancer and diabetes mellitus, and socioeconomic status.
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mortality and a higher intake level. In their meta-analysis, Corrao et al. estimated that the risk 
of CHD mortality is lowest at 16 grams per day with a corresponding hazard ratio of 0.84 (57). 
In the present study, the hazard ratios for CHD mortality were comparable but not statistically 
significant (table 3.2).
 Smoking might confound the association between alcohol intake and mortality. Previous 
results from the Zutphen Study indicated that the number of cigarettes smoked as well as the 
duration of cigarette smoking are, independently of each other, associated with mortality (58). 
In our multivariable analyses, we adjusted for these aspects of smoking. So, it is not likely 
that the association between alcohol intake and mortality is explained by confounding due to 
smoking.
 In the present study, wine consumption was associated with a lower mortality risk, 
independent of total alcohol intake. Some studies did not demonstrate a favourable effect of 
one specific type of alcoholic beverage over another (14;42), while others found an inverse and 
independent association between wine consumption and mortality (13;59-61). In the present 
study, 70% of all wine consumed was red wine. This suggests that the cardioprotective effect 
of wine could be due to a protective effect of polyphenolic compounds in red wine, but other 
explanations can not be ruled out.
 Socioeconomic status might confound the association between wine consumption and 
mortality. However, in our multivariable analyses we adjusted for socioeconomic status, based 
on occupation at baseline. At the start of the present study, the men were already in a later 
phase in their careers and baseline socioeconomic status was considered to be a good indicator 
during the follow-up period. Furthermore, the increase in the percentage of wine users during 
follow-up was observed in all levels of socioeconomic status, and additional stratified analyses 
showed that the inverse association between wine consumption and mortality was present in all 
socioeconomic classes. These results suggest that the association between wine consumption 
and mortality can not be explained by confounding due to socioeconomic status. 
Long-term wine consumers had about 5 years longer life expectancy at age 50 compared 
to no alcohol users. Of these 5 years, about 2 years can be attributed to an effect of alcohol 
intake and is in accordance with the inverse association between long-term alcohol intake and 
all-cause mortality found in the present study. The remainder 3 years can be attributed to an 
effect of wine consumption. However, given the wide confidence interval, the effect of wine 
as such may be overestimated. To our knowledge, we are the first who studied the effects of 
absolute alcohol intake and type of alcoholic beverage on life expectancy and more studies are 
needed to verify our results.
In conclusion, long-term light alcohol intake is associated with a lower risk of cardiovas-
cular and all-cause mortality risk, and a longer life expectancy. The inverse associations be-
tween wine consumption and mortality remained after adjustment for total alcohol intake. Wine 
consumers had a 5 years longer life expectancy compared to no-alcohol consumers; however, 
more studies are needed to draw conclusions on the strength of the association between wine 
consumption and mortality.
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Abstract
Aim: We aimed to describe the change in long-term trans unsaturated fatty acid intake and 
to assess the relation between recent and long-term trans unsaturated fatty acid intake and 
(sudden) coronary heart disease death. 
Methods and Results: Changes in trans unsaturated fatty acid intake and the effects of recent 
and long-term trans unsaturated fatty acid intake on (sudden) coronary heart disease death were 
investigated in the Zutphen Study, a cohort of 1373 men born between 1900 and 1920, and 
examined repeatedly between 1960 and 2000. Hazard ratios were obtained from time-dependent 
Cox regression models. Average energy intake from trans unsaturated fatty acids decreased 
from 7% in 1960 to about 1% in 2000. Each 2% increase in long-term energy intake from trans 
unsaturated fatty acids was positively associated with sudden coronary death (hazard ratio: 
1.62 [95% CI: 1.01 to 2.60]). We observed no associations between trans unsaturated fatty acid 
intake and sudden death from other causes, nonsudden coronary death and total coronary death.
Conclusions: Average trans unsaturated fatty acid intake decreased remarkably in the Zutphen 
Study between 1960 and 2000. Long-term trans unsaturated fatty acid intake is positively 
associated with sudden coronary death but not with nonsudden and total coronary death. 
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Introduction
Results from several studies suggest that trans unsaturated fatty acids are strongly associated 
with the risk of coronary heart disease (CHD). This possibility is consistent with findings from 
clinical trials showing that these fatty acids increase LDL cholesterol and lower HDL cholesterol 
concentrations in blood (1) and negatively affect other risk factors such as inflammation and 
endothelial function (2). In prospective studies, each 2% increase in energy intake from trans 
unsaturated fatty acids was associated with a 23% increase in the incidence of CHD (3). Little 
is known about the effects of trans unsaturated fatty acid intake on sudden coronary death. 
 For cohort studies in which trans unsaturated fatty acid intake is assessed only at the 
baseline examination, consumption patterns and product composition are assumed to be 
relatively constant over the entire study period. However, it is unlikely that one exposure 
measurement in the past accurately reflect long-term trans unsaturated fatty acid intake, 
because consumption patterns change during the course of a life. Furthermore, it is known that 
the trans unsaturated fatty acid content of foods has changed (4;5). To obtain correct estimates 
of the long-term effects of trans unsaturated fatty acid intake, repeated measures and time-
specific food-composition tables are needed (6;7). Moreover, the use of repeated measures, 
especially the cumulative average method, reduces within-subject variation over time and, 
thereby, reduces misclassification of trans unsaturated fatty acid intake (8). 
 The objective of the present study was to assess the relation between recent and long-term 
trans unsaturated fatty acid intake and (sudden) coronary heart disease death. For this purpose, 
we used 7 repeated measures of trans unsaturated fatty acid intake. 
Methods
Study population
The Zutphen Study started as the Dutch contribution to the Seven Countries Study, a longitudinal 
study of the relations among diet, other risk factors and chronic diseases (9). The Zutphen 
Study has been carried out since 1960 among middle-aged men in Zutphen, an old industrial 
town in the eastern part of the Netherlands with ≈30 000 inhabitants. In 1960, a random sample 
was drawn of 1088 men born between 1900 and 1919 and residing for >5 y in Zutphen. Of 
those men, 878 participated in the Zutphen Study (response rate: 81%), and 872 took part in 
both dietary and physical examinations. The examinations were repeated in 1965 and 1970. In 
1985, the group of 554 survivors was extended with a new random sample of men of the same 
birth cohort. Of the 1266 men who were invited, 939 participated (response rate: 74%), and 
825 took part in both dietary and physical examinations. These examinations were repeated in 
1990, 1995 and 2000.
 Baseline data were collected in 1960, before the Helsinki Declaration was developed, and 
oral consent was obtained for follow-up data. In 1985 and 1990, the study was approved by the 
Medical Ethics Committee of the University of Leiden (Leiden, Netherlands), and, in 1995 and 
2000, by the Medical Ethics Committee of the Netherlands Organisation for Applied Scientific 
Research.
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Assessment of food consumption and trans unsaturated fatty acid intake 
In all dietary surveys, information on habitual food consumption was collected by using 
the cross-check dietary history method (10), adapted to the Dutch diet (11). This method 
provides information about the participant’s usual food consumption pattern, 6-12 mo before 
the interview. From 1985 onwards, the information about the usual food consumption pattern 
was limited to the month before the interview because consumption patterns were much more 
complicated than those in the 1960s. The interviews were carried out by experienced dieticians 
in the spring and early summer. Each participant was interviewed, if possible in the presence 
of his wife, about his usual food consumption during weekdays and on weekends. On the basis 
of this daily pattern, average food consumption during a day or week (the first check) and the 
quantity of foods bought per week (the second check) were estimated and presented to the 
participants for calculation and verification of their food consumption.
 The daily intakes of trans unsaturated fatty acids, total energy, and other nutrients were 
calculated by using time-specific food composition tables to account for changes in product 
composition and qualitative improvements in analytic methods (12-18). Because the trans 
unsaturated fatty acid content of foods was not analyzed before the 1980s, we used a time-
specific food composition table from 1985 to calculate total trans unsaturated fatty acid intake 
in 1960, 1965, and 1970 (16). 
Assessment of potential confounders
Detailed information on type and amount of smoking was collected by using standardized 
questionnaires (19). Information on alcohol intake was obtained from the cross-check dietary 
history method (20). During physical examinations, men’s weight and height were measured 
and body mass index (BMI; in kg/m2) was calculated. Information on the prevalence of 
myocardial infarction, stroke, diabetes mellitus, and cancer was collected throughout the study. 
The men were classified into 4 levels of socioeconomic status according to their occupation at 
baseline.
Case ascertainment
Participants were followed until death, or censored on June 30, 2000. Three participants were 
lost to follow-up during the study and were censored after their last physical examination. 
The final causes of death were ascertained by one clinical epidemiologist (AM) and coded 
according to the Eighth Revision of the International Classification of Diseases (21). Because 
the underlying cause of death in elderly people is often difficult to ascertain, we included both 
primary and secondary causes of death in our analyses. CHD deaths, including cases of sudden 
death, were coded 410–414. Men who died within 2 h after onset of symptoms that were highly 
likely to be coronary and those with a past diagnosis of CHD were called sudden coronary 
deaths. Other cases of sudden death were classified as sudden death from other causes.
Statistical analysis
First, Cox proportional hazard analyses were performed with age as the time variable, and 
with updated information on trans unsaturated fatty acid intake at each round of measurement 
(most recent intake). Second, the cumulative average trans unsaturated fatty acid intake 
was used to better represent long-term intake (8). For those men who were newly included 
57
Trans unsaturated fatty acids and (sudden) coronary death
in the study in 1985, information on food consumption and trans unsaturated fatty acid 
intake was missing for 1960-1970. Because average trans unsaturated fatty acid intake was 
lower in 1985 than in 1960-1970, the use of cumulative averages excluding earlier intakes 
in those men who were newly included in the study in 1985 would underestimate their 
intakes as compared with those of men included in 1960. To adjust for this underestimation, 
the process of multiple imputation (22) of trans unsaturated fatty acid intake and dietary 
covariates between 1960 and 1970 was carried out 5 times in those men who were newly 
included in 1985, by using an adapted version of predicted mean matching (LG Lazzeroni 
et al., unpublished observations, 1990). The SAS code (SAS Institute, Cary, NC) that was 
used for the multiple imputation can be downloaded (Internet: www.rivm.nl/sasmacros). 
 For Cox proportional hazard models, the PHREG procedure of SAS/STAT software 
(Version 9.1; SAS Institute, Inc, Cary, NC) was used. The nutrient density method was used to 
adjust trans unsaturated fatty acid intake for total energy intake; participants were grouped into 
4 categories of intake: <4%, 4-6%, 6-8%, and >8 % of energy. HRs were calculated by using the 
lowest intake category as the reference group and were calculated continuously for every 2% 
increase in energy intake from trans unsaturated fatty acids. The covariates in the model were 
total energy intake without energy from alcohol (kcal), alcohol intake (indicator variables for 
0, >0-20, or >20 g), wine use (yes or no), consumption of fruit and vegetables (g), BMI (in kg/
m2), cigar or pipe smoking (never or long-term former, recent former, or current) (19), cigarette 
smoking duration (divided by 10 y), the daily number of cigarettes smoked (divided by 10), the 
use of a serum cholesterol lowering diet (yes or no), the prevalence of diabetes mellitus (yes 
or no) and baseline socioeconomic status (indicator variables for manual workers, non-manual 
workers, small-business owners and professionals). To estimate the effects of substituting 
trans unsaturated fatty acids for cis unsaturated fat to keep saturated fat intake constant, the 
models were also adjusted for the sum of trans unsaturated fatty acid, cis monounsaturated and 
cis polyunsaturated fat intake and for total saturated fat intake (% of energy). The effects of 
substituting trans unsaturated fatty acids for saturated fat, and thus of keeping cis unsaturated 
fat constant, were estimated in a similar way.
 In the analyses of the most recent intakes, all covariates were updated in each round 
of measurement, and all available data were used for the analyses. In the analyses of long-
term intake, the cumulative average intake of all dietary covariates was calculated up to each 
measurement round, and non-dietary covariates were updated in each round of measurement. 
Because multiple imputations yielded 5 versions of the dataset, analyses of long-term trans fatty 
acid intake were performed 5 times and the results were pooled by using the MIANALYZE 
procedure of SAS/STAT software (Version 9.1; SAS Institute, Inc, Cary, NC). 
Results
Population characteristics
During 40 y of follow-up (average survival age: 77 y), 1130 of the 1373 men participating in 
the Zutphen Study died (table 4.1). A total of 348 men died of CHD, of these deaths 66 were 
sudden coronary deaths (19% of all CHD deaths) and 46 were sudden deaths due to other 
causes (13%).
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In the participants who were included in the study in 1960 and who survived to 2000, average 
trans unsaturated fatty acid intake decreased remarkably from 19 g/2500 kcal of total energy 
intake in 1960 (≈7% of energy) to 4 g/2500 kcal of total energy intake (≈1% of energy) in 2000 
(table 4.1). Among those men who were newly included in the study in 1985, the intake of 
trans unsaturated fatty acids was comparable. Until 1990, solid fats –e.g. hardened margarines 
and cooking and frying fats containing less than 20% linoleic acid– were the major source of 
trans unsaturated fatty acid intake (48-85% of the total intake), after which meat and dairy 
products became the major source (36-48% of the total intake; figure 4.1). The correlation 
coefficients between trans unsaturated fatty acid intake decreased from approximately 0.4 for 
measurements 5 y apart, 0.3 for measurements 10 y apart to <0.3 for measurements >15 y apart.
Trans unsaturated fatty acid intake and (sudden) coronary heart disease death
Long-term energy intake from trans unsaturated fatty acids was significantly related to sudden 
coronary death (table 4.2, figure 4.2). After adjustment for potential confounders, each 2% 
increase in long-term energy intake from trans unsaturated fatty acids was positively associated 
with sudden coronary death (HR: 1.62 [95% CI: 1.01 to 2.60). This association was independent 
of age. Since all sudden coronary deaths occurred among the participants who were included in 
the study from 1960, we repeated our analyses among these men (n = 875) and found a similar 
association. (HR: 1.49 [0.96 to 2.31]). Moreover, a similar association was found when trans 
unsaturated fatty acids were substituted for saturated fat, keeping the intake of cis unsaturated 
fat constant (HR: 1.61 [0.95 to 2.74]). Long-term trans unsaturated fatty acid intake was not 
associated with sudden death from other causes (figure 4.2), nonsudden CHD death (figure 4.2) 
and total CHD death (table 4.2, figure 4.2). 
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Figure 4.1. Changes in trans unsaturated fatty acid intake in subjects in the Zutphen Study (n = 1373), during 40 y 
of follow-up.
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We observed no associations between recent energy intake from trans unsaturated fatty acids 
and (sudden) coronary death (data not shown).
Discussion
We observed a decrease in the average energy intake from trans unsaturated fatty acids from 7% 
to about 1% between 1960 and 2000 in the participants in the Zutphen Study, the Netherlands. 
Each 2% increase in long-term energy intake from trans unsaturated fatty acids was associated 
with a 62% increase in the risk of sudden coronary death. Long-term trans unsaturated fatty 
acid intake was not associated with sudden death from other causes, nonsudden CHD death and 
with total CHD death. 
 The major strength of this study was the collection of detailed information on usual dietary 
intake at each of 7 rounds of examination and on coronary death during the 40 y of follow-up. 
This enabled us to study recent and long-term –i.e. cumulative average– trans unsaturated 
fatty acid intake in relation to (sudden) coronary death. The detailed information on potential 
confounders made it possible to study the independent relations of trans unsaturated fatty acids 
with mortality. 
Table 4.2. Long-term trans unsaturated fatty acid intake in relation to 40-y sudden coronary 
and total coronary heart disease ([CHD] sudden and nonsudden combined) deaths within the 
Zutphen Study1 
Cause of death Unit HR 
2
 
95% CI HR 
3,4
 
95% CI HR 
3,5
 
95% CI 
Sudden coronary (n = 66) 
     
 <4% of energy 1.00 — 1.00 — 1.00 — 
 4-6% of energy 2.05 0.61 to 6.93 2.26 0.54 to 9.57 2.54 0.56 to 11.6 
 6-8% of energy 2.40 0.71 to 8.09 2.07 0.48 to 8.85 2.51 0.50 to 12.7 
 >8% of energy 5.12 1.50 to 17.5 4.12 0.94 to 18.0 5.58 0.92 to 33.7 
        
 Per 2% of energy 1.59 1.22 to 2.08 1.38 1.02 to 1.88 1.62 1.01 to 2.60 
 P for trend6  0.001  0.04  0.04 
CHD (n = 348)      
 <4% of energy 1.00 — 1.00 — 1.00 — 
 4-6% of energy 1.16 0.79 to 1.71 1.07 0.68 to 1.68 1.02 0.65 to 1.60 
 6-8% of energy 1.25 0.83 to 1.88 1.06 0.66 to 1.72 0.97 0.59 to 1.58 
 >8% of energy 1.49 0.94 to 2.36 1.21 0.70 to 2.07 1.04 0.57 to 1.90 
        
 Per 2% of energy 1.15 1.00 to 1.32 1.06 0.90 to 1.25 1.01 0.82 to 1.24 
 P for trend6  0.05  0.47  0.91 
1n = 1373. HR to hazard ratio to obtained from time-dependent Cox proportional hazard model. For long-term intake 
to the cumulative average intake of all dietary covariates was calculated and non-dietary covariates were updated at 
each measurement round; 2Crude HRs; 3Because of missing data in the covariates, the number of events was less in 
the adjusted analyses: i.e. 336 CHD deaths and 63 sudden coronary deaths; 4Adjusted for total energy intake without 
alcohol; alcohol intake; wine use; fruit and vegetable intakes; use of a serum cholesterol-lowering diet; cigarette 
smoking duration and the number of cigarettes smoked/d; cigar or pipe smoking; BMI; prevalence of diabetes 
mellitus; and socioeconomic status; 5Also adjusted for total saturated fat intake and the sum of trans unsaturated fatty 
acid; cis monounsaturated fat; and cis polyunsaturated fat intake; 6Assessed by modelling trans unsaturated fatty acid 
intake continuously. 
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The present study also had some weaknesses. First, trans unsaturated fatty acid intake was 
calculated by using time-specific food composition tables, but the trans unsaturated fatty acid 
content of foods was not available before 1980s.  For the period of 1985 to 1995, Oomen 
et al. created 3 time-specific tables (16). We used the table for 1985 to calculate total trans 
unsaturated fatty acid intake in 1960–1970. Because solid edible fats –i.e. hardened margarines, 
cooking and frying fats containing less than 20% linoleic acid– were the major source of total 
trans unsaturated fatty acid intake from 1960 to 1970 and in 1985 (figure 4.1), we considered 
the estimation of total trans unsaturated fatty acid intake for 1960–1970 valid. Second, for 
those men who were newly included in the study in 1985, information on trans unsaturated 
fatty acid intake was missing for 1960–1970. By using a process of multiple imputation of 
trans unsaturated fatty acid intake and other dietary covariates in 1960-1970, we were able to 
counter an underestimation of cumulative average intake from 1985 onwards for those men who 
were newly included in the study. However, the assumptions that were made in the multiple 
imputation method may have led to less precise effect estimates. Without imputation of the trans 
unsaturated fatty acid intake and other dietary covariates, the associations changed slightly, but 
the overall conclusions remained the same. Therefore, it is unlikely that bias occurred. Third, 
information on physical activity was not collected continuously during the whole follow-
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Figure 4.2. Hazard ratios with 95% CIs, obtained from time-dependent Cox proportional hazard models, for every 
2% increase in long-term energy intake from trans unsaturated fatty acids in relation to 40-y sudden and nonsudden 
coronary heart disease (CHD) deaths within the Zutphen Study (n = 1373). Hazard ratios were adjusted for the sum 
of trans unsaturated fatty acid and cis unsaturated fat intake; total saturated fat intake; total energy intake without 
alcohol; alcohol intake; wine use; fruit and vegetable intakes; the use of a serum cholesterol-lowering diet; cigarette 
smoking duration and the number of cigarettes smoked/d; cigar or pipe smoking; BMI; prevalence of diabetes 
mellitus; and socioeconomic status. Because of missing data in covariates, the number of events was less in the 
adjusted analyses: i.e. 336 CHD deaths, 63 sudden coronary deaths, 45 sudden deaths from other causes and 228 
nonsudden CHD deaths. Sudden coronary deaths were defined as cases of sudden death that were highly likely to be 
coronary and that occurred within 2 h of the onset of symptoms in diagnosed cases or in persons with a past diagnosis
of CHD. Sudden deaths from other causes were defined as cases of sudden death only after a reasonable exclusion 
of cardiac specific causes.
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up period and, therefore, repeatedly collected data was not available for the present study. 
 In the present study, we observed a remarkable decrease in average intake of trans 
unsaturated fatty acids between 1960 and 2000 from 7 to about 1%. In the 1960s, the intake 
of trans unsaturated fatty acids in Zutphen was the highest in the 16 cohort of the Seven 
Countries Study (23). The chemical analyses of a food composite representing the average 
food consumption pattern of the Zutphen men in 1960 obtained an intake of 8% of energy and 
is similar to the 7% obtained by calculation from the food composition tables in the present 
study. This very high intake of trans unsaturated fatty acid intake in the Netherlands in the 
1960s was due to the high content of hydrogenated fish oils in solid fats. The present study 
showed that there was a considerable decrease in trans unsaturated fatty acid intake in the 
Netherlands between 1960 and 2000, and started already before the decision of the Dutch 
margarine producers in 1994 to reduce the trans unsaturated fatty acid content in margarines 
(24;25).
 We found that each 2% increase in long-term energy intake from trans unsaturated fatty 
acids increased sudden coronary death risk by 62%. Similar results were obtained in case-
control studies of biomarkers of trans unsaturated fatty acid intake. In these studies, the 
strongest associations were found for levels of C18:2 trans unsaturated fatty acids (26;27). For 
total trans unsaturated fatty acid intake, the associations were modest (27). To our knowledge, 
we are the first to examine the associations between dietary trans unsaturated fatty acid intake 
and sudden coronary death in detail in a prospective cohort study. Other studies are needed to 
verify our results. 
 The primary cause of sudden coronary death is ventricular fibrillation and studies have 
shown that free fatty acids have arrhythmogenic properties, due to the interaction with 
biological membranes, i.e. lipid bilayers with two hydrophilic surfaces and a hydrophobic 
core. Especially the hydrophobic portions of membrane proteins interact with lipids in the 
core of the bilayer (28). These membrane proteins include the voltage-gated ion channels 
responsible for the cardiac action potential. Alterations in membrane composition, which occur 
when free fatty acids are incorporated in the bilayer, change closing and inactivation of the 
ion channels (28). The arrhythmogenic properties of fatty acids depend on their fatty acyl 
chain length and degree of de-saturation (29;30). Fatty acids with a shorter chain length and 
a lower degree of de-saturation may enhance calcium transport in the biological membranes 
(30). Furthermore, unsaturated fatty acids with a trans configuration may also promote calcium 
transport compared to unsaturated fatty acids with a cis configuration, independent of fatty 
acyl chain length (31). Therefore, it is hypothesized that trans unsaturated fatty acids may have 
proarrhytmic properties and may increase the risk of sudden coronary death (32).
 Our results did not confirm those of an earlier analysis of the Zutphen Elderly Study in 
which a positive relation was found between trans unsaturated fatty acid intake, and fatal and 
nonfatal CHD in the period 1985-1995 (33). In the present study, average trans unsaturated fatty 
acid intake decreased from 7% to ≈1% of energy between 1960 and 2000, and was primarily 
the result of changes in the composition of solid fats (4;5). This remarkable decrease resulted 
in low correlation coefficients for trans unsaturated fatty acid intake between measurements 
rounds, when time between rounds became longer (approximately 0.4 for measurements 5 y 
apart, 0.3 for measurements 10 y apart to <0.3 for measurements >15 y apart). This could be 
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the reason for the absence of a relation between long-term trans unsaturated fatty acid intake 
and CHD death in the present study. 
 We conclude that in the Netherlands, a remarkable decrease in average energy intake from 
trans unsaturated fatty acids was observed from 7 to about 1%. We also found that long-term 
trans unsaturated fatty acid intake was positively associated with the risk of sudden coronary 
death. We did not find an association between long-term trans unsaturated fatty acid intake and 
total CHD death.
Conflict of interest: None declared.
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Abstract
Aims: To assess the relationship between fish consumption or eicosapenaenoic acid 
(EPA)+docosahexaenoic acid (DHA) intake from fish, and (sudden) coronary death.
Methods and results: The impact of recent and long-term fish consumption and EPA+DHA 
intake on (sudden) coronary death was investigated in the Zutphen Study, a cohort of 1373 men 
born between 1900 and 1920, and examined repeatedly between 1960 and 2000. Hazard ratios 
were obtained from time-dependent Cox regression models. The associations between long-
term fish consumption, EPA+DHA intake, and (sudden) coronary death were stronger than 
those of recent consumption. Long-term fish consumption was inversely associated (borderline 
significant) with coronary heart disease (CHD) death; however, the strength of the association 
decreased from age 50 (HR: 0.32 [95%CI: 0.13 to 0.80]) until age 80 (HR: 1.34 [0.58 to 3.12]). 
For men with a daily EPA+DHA intake from fish below 250 mg compared with no intake, 
CHD death risk was reduced to the same extent as for men with a daily intake above 250 
mg (P-value for trend: 0.27). Moreover, long-term fatty-fish consumption lowered the risk of 
sudden coronary death (HR: 0.46 [0.27 to 0.78]). 
Conclusion: The strength of the association between long-term fish consumption and CHD death 
decreased with increasing age. Fatty-fish consumption lowered sudden coronary death risk. There 
was no clear dose-response relationship between EPA+DHA intake and (sudden) coronary death. 
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Introduction
In most prospective cohort studies, consuming a relatively small amount of fish or fish oil 
was associated with a lower risk of coronary heart disease (CHD) death (1) and these results 
were confirmed by several intervention studies (1-5). In a meta-analysis of cohort studies, 
He et al. (1) estimated that consuming fish once a week lowers CHD death risk by 15%. In 
addition, Mozaffarian and Rimm (5) estimated, by combining results from both randomized 
trials and prospective cohort studies, that consuming 250 mg eicosapentaenoic acid 
(EPA)+docosahexaenoic acid (DHA) per day lowers CHD death risk by 36%. 
 EPA (C20:5n-3) and DHA (C22:6n-3), two long-chain n-3 polyunsaturated fatty acids 
mainly found in fatty fish, are the constituents in fish oil that may reduce the risk of CHD death. 
The most likely explanation by which relatively small amounts of EPA and DHA reduce the risk 
of CHD death are their anti-arrhythmic properties (6). They are also suggestive for an inverse 
relation with sudden coronary death (7;8). In observational studies, consuming fish once or 
twice a week was associated with a 42-50% lower risk of sudden coronary death or cardiac 
arrest (9-11). The associations with blood (12) or cell membrane (10) levels of EPA+DHA 
were even stronger. However, little is known about the effect of long-term fish consumption or 
EPA+DHA intake on (sudden) coronary deaths.
 For prospective studies in which fish consumption is only assessed at the baseline 
examination, consumption patterns are assumed to be relatively constant over the entire study 
period. However, it is unlikely that exposure measurements in the past accurately reflect long-
term fish consumption since consumption patterns change during life. To get correct estimates 
of the long-term effects of fish consumption and EPA+DHA intake, repeated measures are 
needed (13;14). 
 The objective of the present study is to assess the relationship between recent and long-
term fish consumption or EPA+DHA intake from fish, and (sudden) coronary death. For this 
purpose, we used up to seven repeated measures of fish consumption and EPA+DHA intake 
from fish collected during 40 years of follow-up in a cohort of middle-aged men.
Methods
Study population
The Zutphen Study started as the Dutch contribution to the Seven Countries Study, a 
longitudinal study of the relationships between diet, other risk factors and chronic diseases 
(15). The Zutphen Study has been carried out since 1960 among middle-aged men in Zutphen, 
an old industrial town in the eastern part of the Netherlands with about 30 000 inhabitants. In 
1960, a random sample was drawn of 1088 men born between 1900 and 1919 and residing 
for at least 5 years in Zutphen. Of those men, 878 participated in the Zutphen Study (response 
rate: 81%) and 872 took part in both dietary and physical examinations. These examinations 
were repeated in 1965 and 1970. In 1985, the group of 554 survivors was extended with a 
new random sample of men of the same birth cohort. Of the 1266 men who were invited, 939 
men participated (response rate: 74%) and 825 men took part in both dietary and physical 
examinations. These examinations were repeated in 1990, 1995 and 2000.
 Baseline data was collected in 1960 before the Helsinki Declaration was developed and 
oral consent was obtained in view of follow-up data. In 1985 and 1990, the study was approved 
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by the Medical Ethics Committee of the University of Leiden, The Netherlands, and in 1995 
and 2000, by the Medical Ethics Committee of the Netherlands Organisation for Applied 
Scientific Research (TNO).
Assessment of fish consumption and fish fatty acid intake
Information on the habitual food consumption was collected by using the cross-check dietary 
history method (16), adapted to the Dutch situation (17;18). This method provides information 
about the participant’s usual food consumption pattern, 6-12 months preceding the interview. 
From 1985 onwards, the information about the usual food consumption pattern was limited 
to the month preceding the interview because consumption patterns from 1985 were much 
more complicated than those in the 1960s. The interviews were carried out by experienced 
dieticians in spring and early summer. Each participant, if possible in the presence of his wife, 
was interviewed about his usual food consumption during weekdays and weekends. Based on 
this daily pattern, average food consumption during a day or week (first check) and the quantity 
of foods bought per week (second check) was estimated and presented to the participants to 
calculate and verify the participants’ food consumption. Total fish consumption was divided 
into fatty (e.g. salmon, mackerel, herring, eel, and sardines) and lean (e.g. codfish, plaice and 
pollack) fish. The daily intake of EPA+DHA from fish in the period 1960-1995 was calculated 
using the digital update of the Dutch food composition table from 1996 (19;20). The daily 
intake of EPA+DHA from fish in 2000 was calculated using the Dutch food composition table 
from 2001 (21). 
Assessment of potential confounders
In all dietary surveys, habitual food consumption and the use of a prescribed diet was recorded 
(17;18). The daily intake of energy and nutrients (including alcohol) was calculated using food 
composition tables close to the year of measurement. Detailed information on the type and 
amount of smoking was collected using standardized questionnaires (22). During physical 
examinations, men’s blood pressure, weight, and height were measured and body mass index 
(BMI) was calculated (kg/m2). Information on the prevalence of diabetes mellitus and other 
chronic diseases was collected and verified by contacting each participant’s general practitioner 
(23). The men were classified into four levels of socioeconomic status according to occupation 
at baseline (24).
Case ascertainment
Participants were followed until death, or censored on 30 June, 2000. Three participants were 
lost to follow-up during the study and were censored after their last physical examination. The 
final causes of death were ascertained by one clinical epidemiologist and coded according to 
the Eight Revision of the International Classification of Diseases (25). Because the underlying 
cause of death in elderly people is often difficult to establish, we included both primary and 
secondary causes of death in our analyses. CHD deaths were coded 410-414, including cases 
of sudden death. Men who died within 2 h after onset of symptoms with a high likelihood to be 
coronary and those with a past diagnosis of CHD were called sudden coronary deaths. 
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Statistical analysis
Cox proportional hazard analyses with age until death or censor date as the time variable 
(26;27) were performed using the PHREG procedure of SAS/STAT software (version 9.1; 
SAS Institute, Inc., Cary, NC). First, we used most recent information on fish consumption 
and EPA+DHA intake from fish (time-dependent variables). Second, we calculated cumulative 
average fish consumption and EPA+DHA intake from fish to better represent long-term intake 
(28). With this method, (sudden) coronary death between 1960 and 1965 was related to fish 
consumption from the 1960 examination round; (sudden) coronary death between 1965 and 
1970 was related to average fish consumption from the 1960 and 1965 examination rounds; 
mortality between 1970 and 1985 was related to average fish consumption from the 1960, 
1965 and 1970 examination rounds, and so on. For those men who were newly included in the 
study in 1985, information on fish consumption and EPA+DHA intake from fish was missing 
in the period 1960-1970. Since average EPA+DHA intake from fish was lower in 1985 than 
in 1960-1970, taking cumulative averages excluding earlier intakes in those men who were 
newly included in the study in 1985 would underestimate their intakes compared with men 
included in 1960. To account for this underestimation, multiple imputation (5 times) (29) of 
fish consumption, EPA+DHA intake from fish, and other dietary covariates between 1960 and 
1970 was carried out among those men who were newly included in 1985, with an adapted 
version of predicted mean matching (30). For each missing observation, the nearest –in terms 
of predicted value– non-missing observation was drawn and assigned as the imputed value to 
the missing observation. The variables, besides fish consumption, EPA+DHA intake, and all 
dietary covariates, that were used to impute the missing observations were age at start and end 
of follow-up, and the indicator variable for (sudden) coronary death. The SAS code that was 
used for the multiple imputation can be downloaded from www.rivn.nl/sasmacros. Analyses 
on long-term, i.e. cumulative average, fish consumption and EPA+DHA intake from fish were 
performed on five imputed datasets and results were pooled using the MIANALYZE procedure 
of SAS/STAT software. For both recent and long-term fish consumption and EPA+DHA intake, 
time of follow-up started at the moment the men were included in the study.
 The participants were divided into consumers and non-consumers of, respectively, total 
fish, fatty fish and lean fish according to their recent and long-term, i.e. cumulative average, 
fish consumption. Additionally, participants were grouped into three groups according to their 
recent and long-term intake of EPA+DHA from fish: 0, >0-250, and >250 mg (5). Hazard ratios 
were calculated using the non-consumers and the no intake category as the reference categories. 
For EPA+DHA intake from fish, a P-value for trend was calculated using the continuously 
distributed variable. A two-sided P-value <0.05 was considered statistically significant.
 The covariates in the multivariable models were total energy intake (kcal per day), alcohol 
intake (indicator variables for 0, >0-20, >20 g per day), wine use (yes or no), fruit and vegetable 
consumption (gram per day), saturated fat, trans unsaturated fatty acid, cis monounsaturated 
fat and cis polyunsaturated fat intake (gram per day), use of a serum cholesterol lowering diet 
(yes or no), cigar or pipe smoking (never or long-term ex, recent-ex or current) (22), cigarette 
smoking duration (divided by 10), the daily number of cigarettes smoked (divided by 10), 
BMI (kg/m2), prevalence of diabetes mellitus (yes or no), systolic blood pressure (mmHg), 
and baseline socioeconomic status (indicator variables for manual workers, non-manual 
workers, small-business owners, and professionals). The separate models for fatty and lean 
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fish consumption were additionally adjusted for each other. In the analyses for the most recent 
intake, all covariates were updated at each measurement round. In the analyses for long-term 
intake, the cumulative average intake of all dietary covariates was calculated and non-dietary 
covariates were updated at each measurement round. To test whether the associations were 
constant over our time variable (age), a product term between fish consumption or EPA+DHA 
intake and age was included in the model, and a P-value for interaction <0.10 was considered 
statistically significant.
Results
Population characteristics
During 40 years of follow-up (mean survival age: 77 years), 348 of the 1373 men participating 
in the Zutphen Study died from CHD (table 5.1). Of these deaths, 66 where sudden coronary 
deaths (19% of all CHD deaths). 
 Among the men who were included in the study in 1960, the percentage of fish consumers 
varied between 71 and 81% between 1960 and 2000 (table 5.1) and average fish consumption 
ranged from 16 to 21 g per day. In all measurement rounds, lean fish was the major type of fish 
consumed (between 58 and 80% of the total fish consumption). Moreover, average EPA+DHA 
intake from fish varied between 136 and 236 mg per day in the period 1960-2000. Among those 
men who were newly included in the study in 1985, fish consumption and EPA+DHA intake 
from fish was comparable to the men who participated since 1960. The correlation between 
EPA+DHA intake from fish and total fish consumption ranged from 0.60 in 2000 to 0.80 in 
1960.
Fish consumption, EPA+DHA intake and CHD death
Long-term, i.e. cumulative average, fish consumers –consuming on average 22 g per day– had 
a 27% lower CHD death risk (P-value: 0.16; table 5.2), while recent fish consumption was not 
associated with CHD death (data not shown).
 For the associations between long-term fish consumption or EPA+DHA intake and CHD 
death, we found a significant and positive interaction with age, indicating that these associations 
were weaker at an older age (figure 5.1A and B). The HRs for long-term fish consumption 
compared with no fish consumption increased from 0.32 (95%CI: 0.13 to 0.80) at age 50 to 
0.65 (0.42 to 1.02) at age 65 (P-value for interaction: 0.06, figure 5.1A). From age 70 onwards, 
the confidence intervals were too wide to draw conclusions from the reported associations. For 
long-term fatty-fish consumption, similar associations were observed (P-value for interaction: 
0.06, figure 5.1A). In addition, we found an inverse association between EPA+DHA intake and 
CHD death among men with an intake below as well as above 250 mg per day compared with 
no intake (figure 5.1B). However, HRs were comparable with those for total fish consumption 
and no dose-response relationship was found (P-value for trend: 0.27; table 5.2). Adjustment 
for the prevalence of chronic disease, i.e. myocardial infarction, stroke and cancer, instead of 
the use of a serum cholesterol lowering diet slightly strengthened the associations between fish 
consumption and CHD death (data not shown).
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Fish consumption, eicosapenaenoic acid+docosahexaenoic acid intake and sudden 
coronary death
Long-term, i.e. cumulative average, fatty-fish consumption –on average 7 g per day– lowered 
sudden coronary death risk by 54%, while no associations were found with total and lean fish 
consumption (table 5.2). Additional analysis showed that the inverse association between fatty-
fish consumption and sudden coronary death was independent of total fish consumption (HR: 
0.41 [95%CI: 0.23 to 0.73]). Although the association between EPA+DHA intake from fish and 
sudden coronary death was stronger among men with an intake above 250 mg than among those 
with an intake below 250 mg compared with no intake, no clear dose-response relationship was 
found (P-value for trend: 0.18; table 5.2). Adjustment for the prevalence of chronic disease 
instead of the use of a serum cholesterol lowering diet slightly attenuated the associations 
between fatty-fish consumption and sudden coronary death, but overall conclusions remained 
the same (data not shown).
 The effects of long-term fish consumption and EPA+DHA intake on other CHD deaths 
were comparable to the effects on total CHD death (data not shown).
Discussion
In the present study, long-term, i.e. cumulative average, fish consumption –on average 22 g 
per day, i.e. 1-2 servings per week– was inversely associated with CHD death. The strength of 
this association decreased with increasing age and remained statistically significant until age 
65. In addition, long-term fatty-fish consumption –on average 7 g per day– lowered the risk of 
sudden coronary death, independent of age. We observed no clear dose-response relationship 
of EPA+DHA intake from fish with (sudden) coronary death.
 The major strength of this study was the collection of detailed information on usual dietary 
intake at each of seven examination rounds and on coronary death during 40 years of follow-
up. This enabled us to study recent and long-term fish consumption and EPA+DHA 
intake from fish in relation to CHD death and sudden coronary death, and to study possible 
interactions with age. Besides, the detailed information on potential confounders made it 
possible to study the independent relationships of fish consumption and EPA+DHA intake from 
fish with mortality. 
 The present study also has some weaknesses. First, the number of sudden coronary deaths 
(66 events) observed in the Zutphen Study may have been too small to detect a dose-response 
relation for EPA+DHA intake. Second, to account for changes in product composition, time-
specific food composition tables are needed to calculate nutrient intake over a longer period of 
time. However, as the digitally updated version of the Dutch food composition database from 
1996 contains values of EPA and DHA in fish obtained with improved laboratory analyses 
compared with values reported earlier, we used this table to calculate EPA+DHA intake from 
fish in the period 1960-1995 (19;20). Third, since frying can affect a fish meal’s fatty-acid 
composition and trans unsaturated fatty acids in frying fats may increase cardiovascular risk, 
Mozaffarian et al. (31) suggested that these factors should be taken into account when studying 
the associations of fish consumption with CHD death. In the present study, it was not possible 
to consider different methods of fish preparation. However, detailed information on usual food 
consumption and nutrient intake made it possible to study the independent effects of lean, 
which is mostly fried, and fatty-fish consumption and to adjust for trans unsaturated fatty 
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Figure 5.1. Hazard ratios, with 95% confidence intervals, for long-term fish consumption (A) and EPA+DHA intake 
from fish (B) in relation to coronary heart disease death at different ages and adjusted for energy intake, alcohol 
intake, wine use, fruit and vegetable consumption, saturated fat, trans unsaturated fatty acid, cis monounsaturated 
and cis polyunsaturated fat intake, serum cholesterol lowering diet, smoking, body mass index, prevalence of diabetes 
mellitus, systolic blood pressure, and socioeconomic status.
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acid intake. Fourth, for those men who were newly included in the study in 1985, information 
on fish consumption was missing in the period 1960-1970. By multiple imputations of fish 
consumption, EPA+DHA intake from fish, and other dietary covariates in 1960-1970, we 
were able to counter an underestimation of cumulative average intake from 1985 onwards 
for those men who were newly included in the study. However, assumptions that were made 
in the multiple imputation method may have led to less precise effect estimates. We repeated 
our analysis among the participants who were included in the study from 1960 (n = 875) and 
found similar associations between long-term fish consumption and (sudden) coronary death. 
Therefore, it is unlikely that the imputation of fish consumption, EPA+DHA intake, and other 
dietary covariates among those men who were newly included in the study from 1985 biased 
our results.
 Our results confirm those from other prospective cohort studies that found an inverse 
association between fish consumption, EPA+DHA intake from fish and CHD death risk (31-
36); however, significant inverse associations were only present until age 65. Compared with 
no intake, long-term EPA+DHA intake was associated with a lower CHD death risk among 
men with an intake below as well as above 250 mg per day and HRs were comparable. This 
confirms the findings from Mozaffarian et al. (5) who showed that a dose-response relationship 
between EPA+DHA intake from fish and CHD death is only present up to an intake of 250 
mg per day, while intakes above 250 mg did not have a significant additional risk reduction.  
 Moreover, the present study showed that long-term fatty fish-consumption –on average 7 
g per day– lowered the risk of sudden coronary death by 54% and confirms results from other 
prospective cohort studies (9;37). Results from two case-control studies suggest that there is 
a linear dose-response relation between blood or cell membrane levels of EPA and DHA, and 
sudden coronary death or cardiac arrest (11;12). In the present study, the association between 
EPA+DHA from fish and sudden coronary death was indeed stronger among men with an 
intake above 250 mg compared with the association among men with an intake below 250 mg; 
however, the trend was not statistically significant (P-value: 0.18). Lean fish consumption was 
not associated with sudden coronary death. Besides the difference in EPA and DHA content, 
fatty fish also has a higher content of other bioactive compounds such as vitamin D (21) than 
lean fish, which could have an additional beneficial effect. Furthermore, as already mentioned 
earlier, lean fish is mostly fried and although we adjusted for trans fatty acid intake, residual 
confounding cannot be ruled out. 
 Within the Zutphen population, average EPA+DHA intake from fish was ~200 mg per 
day. At this low level of intake, an anti-arrhythmic effect of EPA+DHA is the most likely 
explanation for the low risk of (sudden) coronary death (38). At low doses, an increase in 
circulating free EPA and DHA contributes to reducing arrhythmias by binding to the Na+ and 
L-type Ca+ channels in cell membranes. This inhibits the Na+ and L-type Ca+ currents in 
cell membranes, which prevent the generation of action potentials in injured cardiomyocytes 
(6;8;39). 
 The main conclusion of this study is that long-term fish consumption –on average 22 g per 
day– lowers the risk of CHD death, especially below age 65. Fatty-fish consumption lowers the 
risk of sudden coronary death. There is no clear dose-response relationship between EPA+DHA 
intake from fish and (sudden) coronary death.
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Abstract
Background: Little is known about the effects of dietary fiber intake on long-term mortality.
Objective: We aimed to study recent and long-term dietary fiber intake in relation to coronary 
heart disease and all-cause mortality.
Design: The effects of recent and long-term dietary fiber intakes on mortality were investigated 
in the Zutphen Study, a cohort of 1373 men born between 1900 and 1920, and examined 
repeatedly between 1960 and 2000. During that period, 1130 men died, 348 as a result of 
coronary heart disease. Hazard ratios were obtained from time-dependent Cox regression 
models.
Results: Every additional 10 g of recent dietary fiber intake per day reduced CHD mortality 
by 17% (95% CI: 2% to 30%) and all-cause mortality by 9% (0% to 18%). The strength of 
the association between long-term dietary fiber intake and all-cause mortality decreased from 
age 50 y (hazard ratio: 0.71 [95% CI: 0.55 to 0.93]) until age 80 y (0.99 [0.87 to 1.12]). We 
observed no clear associations for different types of dietary fiber.
Conclusions: A higher recent dietary fiber intake was associated with a lower risk of both 
coronary heart disease as well as all-cause mortality. For long-term intake, the strength of the 
association between dietary fiber and all-cause mortality decreased with increasing age. 
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Introduction
Epidemiological studies have shown that consumption of (whole-grain) cereals (1-4) and 
vegetables and fruit (5-8) may lower the risk of coronary heart disease (CHD) mortality. Dietary 
fiber is one of the components that may be responsible for the beneficial effects of these foods. 
Results from intervention trials have shown that (water-soluble) dietary fiber may lower blood 
cholesterol concentrations (9), reduce blood pressure (10;11), promote body-weight loss (12), 
and may improve insulin sensitivity (13) –thereby reducing the risk of CHD mortality (14-
17). In a pooled analysis of cohort studies, total dietary fiber intake was inversely associated 
with the risk of CHD mortality. Furthermore, the intakes of dietary fiber from cereals or from 
fruits were inversely associated, independent of each other, with the risk of CHD mortality 
(14). However, little is known about the effects of long-term dietary fiber intake on all-cause 
mortality.
 For prospective cohort studies in which dietary fiber intake is assessed only at baseline, 
consumption patterns and product composition are assumed to be constant over the entire study 
period. However, it is unlikely that exposure measurements in the past accurately reflect long-
term dietary fiber intake, because consumption patterns change during the life-course. To obtain 
correct estimates of the long-term effects of dietary fiber intake, repeated measures and time-
specific food-composition tables are needed (18;19). Moreover, the use of repeated measures, 
especially when a cumulative average method is used, reduces within-subject variation over 
time and, thereby, reduces misclassification of dietary fiber intake (20).
 The objective of the present study is to investigate recent and long-term total dietary fiber 
intake and dietary fiber intake from various food groups in relation to CHD and all-cause 
mortality. For this purpose, we used up to 7 repeated measures of dietary fiber intake. 
Subjects and methods
Study population
The Zutphen Study started as the Dutch contribution to the Seven Countries Study, a longitudinal 
study of the relations of diet and other risk factors with chronic diseases (21). The Zutphen 
Study has been carried out since 1960 among middle-aged men in Zutphen, an old industrial 
town (≈30 000 inhabitants) in the eastern part of the Netherlands. In 1960, a random sample 
was drawn of 1088 men born between 1900 and 1919 and residing for >5 y in Zutphen. Of 
those men, 878 participated in the Zutphen Study (response rate: 81%), and 872 took part in 
both dietary and physical examinations. The examinations were repeated in 1965 and 1970. In 
1985, the group of 554 survivors was extended with a new random sample of men from the 
same birth cohort. Of the 1266 men who were invited, 939 men participated (response rate: 
74%), and 825 men took part in both dietary and physical examinations. These examinations 
were repeated in 1990, 1995 and 2000.
 Baseline data were collected in 1960 –i.e. before the Helsinki Declaration was developed– 
and oral informed consent was obtained in view of follow-up data. In 1985 and 1990, the 
study was approved by the Medical Ethics Committee of the University of Leiden (Leiden, 
Netherlands); in 1995 and 2000, the study was approved by the Medical Ethics Committee of 
the Netherlands Organisation for Applied Scientific Research (TNO).
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Assessment of food consumption and dietary fiber intake 
In all dietary surveys, information on habitual food consumption was collected by using the 
cross-check dietary history method (22), adapted to the usual Dutch diet (23;24). This method 
provides information about the participant’s usual food consumption pattern in the period 6-12 
mo before the interview. From 1985 on, the information about the usual food consumption 
pattern was limited to the month preceding the interview, because consumption patterns in 
1985 were much more complicated those in the 1960s. The interviews were carried out by 
experienced dieticians in spring and early summer. Each participant was interviewed, in the 
presence of his wife if possible, about his usual food consumption on weekdays and weekends. 
On the basis of this daily pattern, average food consumption during a day or week (first check) 
and the quantity of foods bought per week (second check) were estimated, and those values 
were presented to the participants to calculate and verify their food consumption.
 In the present study, dietary fiber is defined as constituents of plant cells that cannot be 
digested or absorbed in the human stomach and small intestine (25;26), particularly pectin, 
cellulose, hemicellulose, and lignin (27;28). The daily intakes of dietary fiber, total energy 
and other nutrients were calculated using time-specific food-composition tables to account 
for changes in product composition and for qualitative improvements in analytical methods 
(28-33). In addition, intakes of dietary fiber from bread and other cereal products, potatoes, 
legumes, fruits, and vegetables were calculated. Because the ratio of the interindividual and 
intraindividual variance in dietary fiber intake in the Zutphen Study was 2.1, the reproducibility 
of dietary fiber intake was relatively high (34).
Assessment of potential confounders
Detailed information on the type and amount of smoking was collected using standardized 
questionnaires (35). Information on alcohol intake and the use of a prescribed diet was obtained 
from the cross-check dietary history (23;24). During physical examinations, men’s weight and 
height were measured, and body mass index (BMI; in kg/m2) was calculated. Information about 
the prevalence of myocardial infarction, stroke, diabetes mellitus, and cancer was collected 
throughout the study. The men were classified into 4 levels of socioeconomic status according 
to occupation at baseline.
Case ascertainment
Participants were followed until death, or censored on June 30, 2000. Three participants were 
lost to follow-up during the study and were censored after their last physical examination. For 
each participant who died, the final allocation of the cause of death was done by a clinical 
epidemiologist (A Menotti, Association for Cardiac Research, Rome, Italy) and coded 
according to the Eight Revision of the International Classification of Diseases (36). Because 
the underlying cause of death in elderly persons is often difficult to ascertain, we included both 
primary and secondary causes of death in our analyses. CHD deaths, including cases of sudden 
death were codes 410-414. 
Statistical analysis
Before analyses, intakes of dietary fiber and other nutrients were adjusted for total energy 
intake using the nutrient residual method (37). First, Cox proportional hazard analyses were 
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performed with age as the time variable, and information on dietary fiber intake was updated 
at each measurement round (called the most recent intake). Second, the cumulative average 
dietary fiber intake was used to better represent long-term intake (20). For those men who 
were newly included in the study in 1985, information on food consumption and dietary fiber 
intake was missing for the period from 1960 through 1970. Because average dietary fiber intake 
was lower in 1985 than in 1960-1970, taking cumulative averages excluding earlier intakes in 
the men included in 1985 would underestimate their intakes compared with those of the men 
included in 1960. To account for this underestimation, multiple imputation (5 times) (38) of 
dietary fiber intake and other dietary covariates from 1960 through 1970 was carried out among 
those men who were newly included in 1985, with the use of an adapted version of predicted 
mean matching (Lazzeroni et al., unpublished observations, 1990). The SAS code that was 
used for the multiple imputation can be downloaded (Internet: www.rivm.nl/sasmacros). 
 For Cox proportional hazard models the PHREG procedure of SAS/STAT software 
(version 9.1; SAS Institute, Inc, Carry, NC) was used. Hazard ratios (HRs) were calculated 
for every additional 10 g of energy-adjusted total dietary fiber intake and for energy-adjusted 
dietary fiber intake from bread and other cereal products, potatoes, legumes, vegetables, and 
fruit. The covariates in the model were total energy intake (kcal); trans unsaturated fatty 
acid, saturated fat and cis polyunsaturated fat intakes (nutrient residuals) (37); alcohol intake 
(indicator variables for 0, >0-20, >20 g/d); wine use (yes or no); fish intake (g/d); BMI (kg/
m2); cigar or pipe smoking (never or long-term former, recent former, or current) (35); cigarette 
smoking duration (divided by 10 y), the daily number of cigarettes smoked (divided by 10); 
use of a prescribed diet (yes or no); and baseline socioeconomic status (indicator variables for 
manual workers, non-manual workers, small-business owners and professionals). A possible 
interaction between dietary fiber intake and age was tested, and P for interaction <0.10 was 
considered statistically significant.
 In the analyses for most recent intake, all covariates were updated at each measurement 
round, and all available data were used for the analyses. In the analyses for long-term intake, 
the cumulative average intake of all dietary covariates was updated at each measurement round. 
Nondietary covariates were updated with the most recent value at each measurement round. 
Because multiple imputations yielded 5 versions of the dataset, analyses of long-term dietary 
fiber intake were performed 5 times, and the results were pooled by using MIANALYZE in 
SAS/STAT.
Results
Population characteristics
During 40 y of follow-up (mean survival age: 77 y), 1130 of the 1373 men participating in the 
Zutphen Study died (table 6.1). A total of 348 men died of CHD.
 Among the participants who were included in the study in 1960, average daily dietary 
fiber intake decreased remarkably –from 33 g/d in 1960 to 21 g/d among the survivors in 2000. 
In addition, average total energy intake decreased from 3107 kcal/d in 1960 to 2073 kcal/d 
in 2000. Consequently, average daily dietary fiber intake per 2500 kcal remained relatively 
constant during 40 y of follow-up (table 6.1). Among those men who were newly included in 
the study in 1985, the average daily intake of dietary fiber was comparable to that in men who 
started the study in 1960. 
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Dietary fiber and (coronary) mortality
Bread and other cereal products were the major source of total dietary fiber intake (between 
29% and 34% of total dietary fiber intake) in all survey rounds (figure 6.1). Total dietary 
fiber intake was most strongly correlated with dietary fiber intake from bread and other cereal 
products; correlation coefficients varied between 0.65 in 1995 and 0.78 in 1970.
Dietary fiber intake and mortality
After adjustment for potential confounders, every additional 10 g of recent dietary fiber intake 
was inversely associated with CHD (HR: 0.83 [95%CI: 0.70 to 0.98]; table 6.2) and all-cause 
mortality (0.91 [0.82 to 1.00]; table 6.3). In crude analyses, every additional 10 g of long-term 
dietary fiber intake was inversely associated with all-cause mortality. However, adjustment 
for potential confounders attenuated this association, and the HR increased from 0.88 (0.79 to 
0.98) to 0.93 (0.83 to 1.04) (table 6.3).
 For the association between long-term dietary fiber intake and all-cause mortality, we 
observed a significant and positive interaction with age (P = 0.03), which indicated that these 
associations weaken at a greater age. For all-cause death, the HR for every additional 10 g 
of long-term dietary fiber intake increased from 0.71 (0.55 to 0.93) at age 50 y to 0.99 (0.87 
to 1.12) at age 80 y (figure 6.2). For CHD mortality, the increase in HRs was comparable, 
but the associations were not statistically significant (figure 6.2). We did not observe clear 
differences in the effects of dietary fiber from various sources on either CHD (table 6.2) or all-
cause mortality (table 6.3).
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Figure 6.1. Changes in dietary fiber intake from various sources within the Zutphen Study (n = 1373) during 40 y 
of follow-up. 
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Figure 6.2. Adjusted hazard ratios (and 95% CIs) at different ages, obtained from time-dependent Cox proportional 
hazard models, for every additional 10 g of long-term energy-adjusted dietary fiber intake (by using the nutrient 
residual method) (37) in relation to 40-y coronary heart disease (A; n = 336) and all-cause (B; n = 1048) 
mortality within the Zutphen Study (n = 1373). Hazard ratios were adjusted for total energy, saturated fat, trans 
unsaturated fatty acid and cis polyunsaturated fat intakes; alcohol intake; wine use; fish intake; prescribed diet; 
the number of cigarettes smoked; duration of cigarette smoking; cigar or pipe smoking; BMI; and socioeconomic 
status. P for interaction with age = 0.26 for coronary heart disease mortality and 0.03 for all-cause mortality. 
Because of missing data in the covariates, the number of events was less than that mentioned in table 6.1. 
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Discussion
In the present study, recent dietary fiber intake was inversely associated with both CHD and 
all-cause mortality. For long-term intake, the strength of the associations between dietary fiber 
and all-cause mortality decreased with increasing age. We observed no clear differences in the 
effect of dietary fiber intake from various food groups on mortality.
 The major strength of the present study was the collection of detailed information on usual 
dietary intake at each of 7 examination rounds and on coronary death during 40 y of follow-up. 
This enabled us to study recent and long-term –i.e. cumulative average– dietary fiber intakes 
in relation to coronary and all-cause mortality and to study a possible interaction with age. 
The detailed information on potential confounders made it possible to study the independent 
relations of (various sources of) dietary fiber intake with mortality. 
 The present study also has some weaknesses. First, for those men who were newly included 
in the study in 1985, information about dietary fiber intake was missing for the period of 1960 
to 1970. By multiple imputation (38) of dietary fiber intake and other dietary covariates in 
1960-1970, we were able to counter an underestimation of cumulative average intake from 
1985 for those men who were newly included in the study. However, the assumptions that were 
made in the multiple imputation method may have led to less precise effect estimates. Without 
imputation of dietary fiber intake and other dietary covariates, the associations between long-
term dietary fiber intake and mortality were slightly attenuated, but the overall conclusions 
remained the same. Therefore, it is unlikely that bias occurred. Second, information on physical 
activity was not collected continuously during the whole follow-up period and therefore was 
not available for the present study. Adjustment for total energy intake per kg body weight as a 
proxy for physical activity (39) did not change our results.
 Our results confirm those from large prospective cohort studies that found an inverse 
association between dietary fiber intake and CHD mortality (40-42). Pereira et al. (14) conducted 
a pooled analysis of 10 cohort studies from the United States and Europe and estimated that 
every additional 10 g of dietary fiber/d reduced CHD mortality risk by 19%. We found a similar 
association of recent dietary fiber intake and CHD mortality. In the pooled analysis of Pereira et 
al. (14), this association became stronger (HR: 0.73 [95%CI: 0.61 to 0.87]) after adjustment for 
measurement error (by using the regression calibration method) in dietary fiber intake. In the 
present study, the cumulative average dietary fiber intake was used not only to better represent 
long-term intake but also to reduce measurement error by reducing the within-subject variation 
of dietary fiber intake over time (20). Until age 70 y, the effects of cumulative average dietary 
fiber intake on CHD mortality were indeed stronger than those of recent intake; however, the 
observed associations were not statistically significant.
 Moreover, Pereira et al. (14) observed that dietary fiber intakes from cereals or from fruit 
were, independent of each other, inversely associated with the risk of CHD mortality. Every 
additional 10 g of dietary fiber intake from cereals lowered CHD mortality risk by 29%, and 
that of dietary fiber from fruit lowered CHD mortality risk by 35%. In the present study, we did 
not observe a clear difference between the effects of dietary fiber from various sources on CHD 
mortality. Because total dietary fiber intake was inversely associated with mortality, the intake 
of all types of fiber-rich foods should be encouraged.
 Several mechanisms have been proposed by which dietary fiber may reduce CHD mortality 
risk (16). Soluble fibers increase the rate of bile acid excretion by binding bile acids in the small 
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intestine, thereby reducing serum total and LDL cholesterol (43-45). In the large intestine, 
soluble fibers are fermented by bacteria. One of the by-products of this process is short-chain 
fatty acids. Hepatocytes, when exposed to these short-chain fatty acids, may increase glucose 
oxidation, decrease free fatty acid release and insulin clearance, and improve insulin sensitivity 
(46;47). The increase in insulin sensitivity results in lower circulating insulin concentrations, an 
effect that has been shown to reduce blood pressure (48). Moreover, the short-chain fatty acids 
inhibit cholesterol synthesis by limiting the action of 3-hydroxy-3-metylglutaryl-coenzyme A 
reductase (46). The effects of dietary fiber on LDL cholesterol, insulin sensitivity, and blood 
pressure may explain the inverse association between dietary fiber intake and CHD mortality. 
In the present study, the associations between dietary fiber intake and mortality were stronger 
for recent intake than for long-term intake. Moreover, the effects of long-term dietary fiber 
were stronger at younger ages –in other words, when dietary fiber intake was calculated over 
a shorter period of time. This finding suggests that the mechanisms by which dietary fiber may 
reduce mortality are primarily short-term effects.
 Besides the inverse association between dietary fiber intake and CHD mortality, we 
observed a significant and inverse association with all-cause mortality, which confirmed the 
results from Todd et al. (49) and Kromhout et al. (50). However, for long-term dietary fiber 
intake, an inverse association with all-cause mortality was present only until age 70 y. Because 
the effects on all-cause mortality were less strong than those on CHD mortality, the inverse 
association between dietary fiber intake and all-cause mortality is mainly explained by the 
inverse association with CHD mortality.
 In conclusion, recent dietary fiber intake was inversely associated with CHD and all-cause 
mortality risk. For long-term intake, the strength of the associations between dietary fiber and 
all-cause mortality decreased with increasing age. Differences between the effects of various 
sources of dietary fiber on mortality were not observed.
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The main objective of this thesis was to assess the relationships between recent and long-term 
exposure to known lifestyle and dietary risk factors, and cardiovascular mortality among men 
participating in the Zutphen Study. For this purpose, we used up to seven repeated measures 
of lifestyle factors and dietary habits in the period 1960-2000. In addition to hazard ratios, we 
presented some of our results in terms of differences in life expectancy at age 50.
Main findings
The main findings of the studies described in this thesis are summarized in table 7.1 and 7.2. 
Within the Zutphen Study, we found that both the number of cigarettes smoked and smoking 
duration were strongly associated with mortality risk (chapter 2). Long-term cigarette smoking 
decreased life expectancy by about 7 years and exclusive cigar or pipe smoking decreased life 
expectancy by about 5 years.  Stopping smoking cigarettes at age 50 increased life expectancy by 
3.3 years. Furthermore, we observed that long-term light alcohol intake lowered cardiovascular 
and all-cause mortality risk (chapter 3). Compared to men who do not consume alcohol, light 
wine consumers had a 5 years longer life expectancy. Next, we showed that average trans 
unsaturated fatty acid intake in the Zutphen Study decreased from 7 to about 1 percent of 
energy intake between 1960 and 2000 (chapter 4) and that long-term trans unsaturated fatty 
acid intake was positively associated with sudden coronary death. In contrast, long-term fatty 
fish consumption was inversely associated with sudden coronary death (chapter 5). The strength 
of the association between long-term total fish consumption and coronary heart disease (CHD) 
death decreased with increasing age. We observed no clear dose-response relationship between 
the intake of the n-3 fatty acids EPA+DHA and (sudden) coronary death. Finally, we found that 
a higher recent dietary fiber intake was associated with a lower risk of both CHD as well as 
all-cause mortality (chapter 6). 
Methodological considerations
The Zutphen cohort
The Dutch contribution to the Seven Countries Study, the Zutphen Study, has been carried 
out since 1960 among middle-aged men. Zutphen is an old industrial town in the eastern part 
of the Netherlands with about 30 000 inhabitants. In 1960, a 4/9 statistical sample was drawn 
from all men born between 1900 and 1919 and residing at least 5 years in Zutphen (n = 1088). 
Of those men, 878 participated in the Zutphen Study (response rate: 81%). Examinations were 
repeated in 1965, 1970, 1985, 1990, 1995 and 2000. In 1985, the group of 554 survivors was 
extended with a new random sample of men of the same birth cohort. Of the 1266 men who 
were invited in 1985, 939 men participated (response rate: 74%). In total 1437 men participated 
in the Zutphen Study. In every examination round, the participants that took part in both the 
dietary and physical examinations were selected for the studies described in this thesis (n = 
1373).
 Extending the 1960 cohort with a new random sample of men in 1985 increased the power 
of the study, but it also has a major limitation. For those men who were newly included in the 
Zutphen Study from 1985, information on lifestyle factors and food consumption was missing 
from 1960 through 1970. Within the Zutphen Study, we observed that average alcohol intake 
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was higher in 1985 than in 1960-1970 (chapter 3). Calculating long-term, i.e. cumulative 
average, alcohol intake ignoring earlier intakes in those men who were newly in the study in 
1985 would overestimate their intake compared with men included in 1960. In contrast, average 
trans unsaturated fatty acid intake was lower in 1985 than in 1960-1970 (chapter 4) and the 
use of cumulative averages ignoring earlier intakes in those men who were newly included in 
the study in 1985 would underestimate their intakes as compared with those of men included 
in 1960. To account for this over- or underestimation, multiple imputation (5 times) (1) of 
the dietary exposure variables and other dietary covariates between 1960 through 1970 was 
carried out among those men who were newly included in 1985, with an adapted version of 
predicted mean matching (2). For each missing observation, the nearest –in terms of predicted 
value– non-missing observation was drawn and assigned as the imputed value to the missing 
observation. The variables, besides the dietary covariates, that were used to impute the missing 
observations were age at start and end of follow-up, and indicator variables for the outcome. 
The SAS code that was used for the multiple imputation can be downloaded from www.rivm.
nl/sasmacros. Analyses on long-term, i.e. cumulative average, exposure were performed on 
five imputed datasets and results were pooled using the MIANALYZE procedure of SAS/
STAT software. To check whether the multiple imputation method did not bias our results, 
we repeated all our analyses without the imputation. Although the effect estimates changed 
slightly, overall conclusions remained the same.
Long-term exposure
The main objective of this thesis was to compare the effects of most recent exposure with 
the effects of long-term exposure to known lifestyle and dietary factors on mortality. For 
most recent exposure, information on lifestyle factors and dietary intake was updated at each 
measurement round. In other words, exposure between 1960 and 1965 was calculated from 
lifestyle factors and dietary intake from the 1960 examination round; exposure between 1965 
and 1970 was calculated from lifestyle factors and dietary intake from the 1965 measurement 
round, and so on. To better represent long-term exposure, we calculated cumulative averages. 
With this method, exposure between 1960 and 1965 was calculated from lifestyle factors and 
dietary intake from the 1960 examination round; exposure between 1965 and 1970 calculated 
from the average exposure to lifestyle and dietary factors from the 1960 and 1965 examination 
rounds, and so on (3). Averaging repeated measures reduces within-subject variation over time 
and, thereby, reduces measurement error (3;4). For example, average trans unsaturated fatty 
acid intake in the Zutphen Study decreased from 7 to about 1 percent of total energy intake 
during 40 years of follow-up (chapter 4) and the correlation between the first two measurement 
rounds was 0.4 compared to 0.3 between the last two measurement rounds. For a measurement 
with an intra class correlation of 0.3, the ratio of between-subject and within-subject variation 
is 1:2.33, yielding a attenuation coefficient of 0.46 (table 7.3). This means that the regression 
coefficient observed when fitting a model on the observed exposures, will be 0.46 of the true 
regression coefficient between the exposure and the outcome. For example, an observed 
regression coefficient of 0.41 –which corresponds to a HR of 1.50– will attenuate to 0.19 
(0.41*0.46; corresponding HR: 1.21) when taking the attenuation coefficient into account. 
By averaging, for example, 4 measurements, the ratio of between-subject and within-subject 
variation changes to 1:(2.33/4) and results in an attenuation coefficient of 0.63 (table 7.3). 
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The more repeated measures, the lower the within-subject variation which results in higher 
attenuation coefficients. This indicates that the long-term, i.e. cumulative average, exposure 
will yield regression coefficients that are closer to the true coefficients. 
The use of repeated measures may also give more insight into the etiology of diseases. With 
the exception of dietary fiber intake, the effects of long-term exposure to the known lifestyle 
and dietary factors on mortality were stronger than those of recent exposure. This suggests that 
long-term exposure is etiologically more relevant than most recent exposure. However, this can 
not be concluded with certainty because it is not possible to separate the effects of reduction 
in measurement error from the truly stronger etiologic relationship with long-term exposure 
than with recent exposure. Hu et al. also observed stronger effects of the cumulative average 
exposure on CHD than of baseline or recent exposure (3) and recognize the fact that this 
method can not separate the effects of reduced measurement error from etiological relevance. 
On the other hand, a stronger effect of recent exposure, such as for dietary fiber intake (chapter 
6), indicates real etiological relevance of recent rather than long-term exposure, as this can not 
be explained by the effects of measurement error. In line with Hu et al. (3), we feel that there 
are probably other sensible ways to update diet that need to be explored in further research.
 The use of a cumulative average exposure is only one aspect of reducing measurement error 
in the assessment of long-term exposure to lifestyle and dietary habits, namely the reduction in 
within-subject variation. Furthermore, it is important to perform repeated measures of lifestyle 
and dietary habits over a longer period of time to take into account changes in these habits 
during the course of life. In the Zutphen Study, information on lifestyle and dietary habits was 
collected seven times during 40 years of follow-up. In principle, the data was collected every 
five years; however, not in the period from 1970 through 1985. Finally, the use of repeated 
measures of lifestyle and dietary habits does not reduce the systematic measurement error 
of the method used for collecting these data, i.e. the respondent specific bias in self-reported 
lifestyle and dietary habits. Therefore, the additional use of biomarkers of lifestyle and dietary 
habits when assessing the exposure to lifestyle and dietary habits is recommended (5).
Table 7.3. Improvement of the validity of a measurement by averaging k repeated measures 
Attenuation coefficients2 Intra class 
correlation1 k=2 k=3 k=4 k=5 k=6 k=7 
0.10 0.18 0.25 0.31 0.36 0.40 0.44 
0.20 0.33 0.43 0.50 0.56 0.60 0.64 
0.30 0.46 0.56 0.63 0.68 0.72 0.75 
0.40 0.57 0.67 0.73 0.77 0.80 0.82 
0.50 0.67 0.75 0.80 0.83 0.86 0.88 
0.60 0.75 0.82 0.86 0.88 0.90 0.91 
0.70 0.82 0.88 0.90 0.92 0.93 0.94 
0.80 0.89 0.92 0.94 0.95 0.96 0.97 
0.90 0.95 0.96 0.97 0.98 0.98 0.98 
1The intra class correlations are defined as the between-subject variation divided by the sum of between-subject 
and within-subject variation; 2The attenuation coefficients are calculated from the intra class correlation 
coefficients by dividing the within-subject variation by the number of measurements.  
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Sudden death
In the Zutphen Study, sudden death was defined as death within 2 hours after the onset of 
symptoms. Men who died suddenly with a past diagnosis of CHD or with symptoms likely to 
be coronary were classified as sudden coronary deaths. Other cases of sudden death had a low 
likelihood to be coronary. In the present study, 60% of the sudden death cases were of coronary 
origin. Goraya et al. (6) found in the Olmsted County population of men above the age of 25, 
that about 50% of all sudden cardiac deaths had a prior diagnosis of CHD. 
 Because the risk of atherosclerotic coronary disease increases with age, the risk of sudden 
death is also expected to increase with age. However, most of the sudden coronary deaths in the 
Zutphen Study occurred before the 1985 measurement round, i.e. when the men were relatively 
young. At an older age, the probability of dying from multiple causes increases. In that case, 
competing causes of death decrease the probability that sudden coronary death will be the 
primary cause of death.
 In the Zutphen Study, all sudden coronary deaths occurred among the men who were 
included in the study in 1960. As a consequence, the inclusion of a new random sample of men 
from the same birth cohort in 1985 was not necessary for analyses on this endpoint. Therefore, 
we repeated our analyses on the sudden coronary death among the men who started the study 
from 1960. For both trans unsaturated fatty acids (chapter 4) and (fatty) fish consumption 
(chapter 5), the overall conclusions did not change.
Age as time-variable
In the analyses on epidemiological cohort data, time between the first examination round and 
the event or end of follow-up is generally used. In the studies described in this thesis, age was 
used as the time-variable. Time at entry was age on December 31st of the year preceding the 
year the men participated in both the dietary and physical examinations for the first time, i.e. 
the first measurement round; exit time was age when the participants died, were lost to follow-
up, or were censored at the end of the follow-up period, whichever came first. By using age as 
the time variable, the hazard function can be directly interpreted as the age-specific incidence 
function (7;8). Moreover, since age is taken into account in the non-parametric term of the 
hazard function, age is most effectively controlled for (7;8).
 To test whether the observed associations were constant over age (our time-variable), 
we included a product term between the exposure variable of concern and age in our models 
and a P-value for interaction <0.10 was considered significant. We found that the inverse 
association between long-term fish consumption and CHD mortality (chapter 5), and the 
inverse association between long-term dietary fiber intake and all-cause mortality (chapter 6) 
weakened with increasing age. These findings suggest that beneficial effects of both long-term 
fish consumption and long-term dietary fiber intake may be restricted to men until age 70. 
However, from age 70 onwards, the confidence intervals were too wide to draw conclusions 
from the reported associations. 
Confounding
Socioeconomic status
There is consistent evidence for an inverse relationship between different indicators of 
socioeconomic status and  cardiovascular diseases (9;10). Traditional indicators of socioeconomic 
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status include occupation, education and income (9;11). Data on socioeconomic status was not 
collected continuously at each measurement round of the Zutphen Study. Therefore, we used 
baseline occupation as an indicator of socioeconomic status. Occupation forms a structural 
link between education and income and it provides a measure of environmental and working 
conditions, latitude in decision-making, and physical demands of the job (11). On the other 
hand, occupational classes are comprised of heterogeneous occupations with substantial 
variation in education, income and prestige. Furthermore, it is difficult to classify those who 
work at home or those who are retired (11). For those men who started in the Zutphen Study 
in 1960, average age was 49 years and only a few men will have changed their jobs during 
follow-up but retired instead. In 1985, when the men were between 65 and 84 years of age, 
only a small number of participants indicated to have a paid job and information on the longest 
held occupation was collected. The information on socioeconomic status from 1960 and 1985 
showed substantial agreement (Cohen’s kappa: 0.61). So, the men were already in a late phase 
in their careers at the start of the study and we considered baseline occupation a good indicator 
of socioeconomic status during the follow-up period.
 Occupation, education and income appear to be independently of each other related to 
dietary habits (12;13). As reviewed by Darmon et al., people with a higher socioeconomic 
status tend to consume more whole grains, lean meats, fish, low-fat dairy products, vegetables 
and fruits, while the consumption of refined grains and added fats has been associated with 
lower socioeconomic status (14). Moreover, Nielsen et al. indicated that effect of specific 
alcohol beverages, especially wine, on mortality may be restricted to certain socioeconomic 
classes (15). In the Zutphen Study, the increase in the percentage of wine users during follow-
up was observed in all levels of socioeconomic status. Among manual workers, the percentage 
of wine users increased from 0% in 1960 to 41% in 2000; among professionals, the percentage 
of wine users increased from 13% to 85%.  Moreover, stratified analyses showed that the 
inverse association between wine consumption and mortality was present in all socioeconomic 
classes (chapter 3). These findings suggest that the association between wine consumption and 
mortality can not be explained by confounding due to socioeconomic status.
Physical activity
Regular physical activity decreases the risk of cardiovascular diseases, including coronary 
heart disease (16;17) and stroke (18). Leisure time physical activity is associated with a 12 to 
27% reduction in the coronary heart disease risk (19). During the whole follow-up period of 
the Zutphen Study, different methods were used to quantify physical activity. Therefore, we 
felt that the available data could not be used in our analyses. However, the lack of adjustment 
for physical activity could cause residual confounding as it tends to be directly associated with 
food consumption, especially fruit and vegetables, and dietary fiber intake (20-24). Previous 
analyses within the Zutphen Study showed that energy intake divided by kg body weight is 
significantly correlated with physical activity (r=0.35, P-value <.0001) (25). This finding 
suggested that in epidemiological studies, total energy intake divided by kg body weight can 
be used as a proxy for physical activity. In our analyses on dietary fiber intake in relation to 
coronary heart disease and all-cause mortality, we adjusted our models for total energy intake 
per kg body weight instead of total energy intake and body mass index. Overall conclusions 
did not change (chapter 6).
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Public health relevance
Life expectancy
In epidemiological studies, hazard ratios are commonly used to express the impact on all-cause 
mortality. Since hazard ratios express effects for an exposed group relative to the effect of 
the unexposed group, they do not provide information regarding absolute health effects. Such 
insight can be obtained by the calculation of life expectancies. Life expectancy is the average 
number of years, calculated for any specified age, a human has before death and is by definition 
an arithmetic mean, i.e. average survival time. In the Zutphen Study, differences in average 
survival time or life expectancy at age 50 were estimated by calculating areas under survival 
curves (26). We used stratified Cox models to obtain the survival curves. For smoking, the 
models were stratified by categories of smoking status or the number of cigarettes smoked; 
for alcohol intake, the models were stratified by categories of amount or type of alcoholic 
beverage. The Cox models were additionally adjusted for baseline covariates, i.e. dietary and 
smoking variables, BMI, prevalence of chronic diseases, and socioeconomic status. Ninety-five 
percent confidence intervals were obtained using the bootstrap method (27).
 We observed that smoking was positively associated with all-cause mortality and that 
overall smoking reduced life expectancy at age 50 by 6.5 years (chapter 2). In contrast, light 
alcohol intake –especially alcohol from wine (chapter 3)– was inversely associated with all-
cause mortality and wine consumers had a 5 years longer life expectancy compared to men 
who do not consume alcohol. The beneficial effects of light to moderate alcohol intake can be 
explained by a lower risk of cardiovascular mortality (28;29), while smoking not only increases 
the risk of cardiovascular diseases (30) but also the risk of cancer (31) and COPD (32).
 The individual effects of alcohol and smoking are well established, but the joint effect of 
these lifestyle factors remains unclear. Studies have found that the beneficial effect of moderate 
alcohol intake on mortality is offset by smoking (33;34). In additional analyses, we estimated 
the joint effect of wine consumption and overall smoking on all-cause mortality (figure 7.1). 
The HR associated with wine use increased from 0.40 (0.31 to 0.51) for never or long-term 
former smokers to 0.67 (0.53 to 0.84) for current smokers. Although the interaction between 
wine use and overall smoking was not statistically significant, the joint effect of wine use and 
not smoking on mortality was stronger than the sum of the individual effects. 
Sudden death
Because 50% of all CHD deaths are sudden, preventing sudden deaths by changes in lifestyle 
and dietary habits is of great importance for public health. Eicosapentaenoic acid (C20:5n-3, 
EPA) and docosahexaenoic acid (C22:6n-3, DHA) –two very long-chain n-3 polyunsaturated 
fatty acids mainly found in fatty fish– are suggestive for an inverse relation with sudden cardiac 
death (35;36) because or their anti-arrhythmic properties (37). We observed that long-term fatty 
fish consumption lowered the risk of sudden coronary death (HR 0.46 [0.27 to 0.78]; chapter 
5). In contrast, each 2% increase in long-term energy intake from trans unsaturated fatty acids 
was positively associated with sudden coronary death (HR 1.62 [1.01 to 2.60]; chapter 4). 
Moreover, dietary fiber intake was not associated with sudden coronary death (unpublished 
observation). 
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The beneficial effect of n-3 polyunsaturated fatty acids on the risk of sudden cardiac death 
has been demonstrated, and other fatty acids such as trans unsaturated fatty acids have also 
been associated with sudden cardiac death (38). Lifestyle factors, such as smoking habits and 
alcohol consumption, may also influence the risk of sudden cardiac death. In subjects with 
and without a history of coronary heart disease, cigarette smoking was an independent risk 
factor for sudden cardiac death (39-43). Moreover, smoking cessation significantly reduces 
the risk of sudden cardiac death (40). In addition, studies have shown associations between 
alcohol consumption and sudden cardiac death (44). Moderate alcohol intake has been shown 
to reduce the risk (45), while a high intake may increase the risk of sudden cardiac death 
(39;46). Generally, lifestyle and dietary risk factors for sudden cardiac death seem to be the 
same as those for atherosclerotic coronary disease (47). 
Future research
The main objective of this thesis was to assess the relationships of recent and long-term 
exposure to known lifestyle and dietary risk factors with mortality. With the exception of 
dietary fiber intake, the effects of long-term exposure to the known lifestyle and dietary factors 
on mortality were stronger than those of recent exposure. However, with the method used 
to calculate the long-term exposure, it is not possible to assess whether the stronger effects 
are due to the reduction in measurement error or a greater etiologic relevance. If the long-
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Figure 7.1. Combined effect of long-term wine use and smoking habits on all-cause mortality within the Zutphen 
Study. Hazard ratios are adjusted for total alcohol intake, former drinker, energy intake without energy from alcohol, 
body mass index, prevalence of myocardial infarction, diabetes mellitus, stroke, and cancer, and socioeconomic 
status.
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term exposure is indeed of greater etiological relevance, this is of great interest for public 
health recommendations. After all, to profit from dietary or lifestyle habits that have a long-
term effect, changes in these habits should be made early in life. So, the challenge for future 
research would be to separate the effect of reduced measurement error from the etiological 
relevance when studying long-term exposure. One way to do this is by multiple measurements 
of dietary and lifestyle habits at each examination round. With this method, the extent of the 
measurement error due to within-subject variation can be determined and be used to adjust for 
in future analyses. A number of things should be considered when using such a study design. 
First, how long should the period between two measurements be. If the intermediate period is 
too long, you cannot be sure whether the change in exposure is due to measurement error or 
is a ‘real’ change. On the other hand, the intermediate period should not be too short to avoid 
memory effects, i.e. earlier reported values are produced from memory. Second, the period 
between the examinations also influences the method of data collection. When measuring the 
exposure repeatedly in a short period of time, the method should be quick and easy to use. 
Third, how many participants should you include in such a study. A large cohort study has 
better power, but it will be very difficult, both logistically as well as financially, to examine all 
participants frequently. Possibly, a subsample of the entire cohort could be used to determine 
the extent of the measurement error due to within subject variation. Repeated measures of 
lifestyle and dietary habits can be used to reduce measurement error due to within-subject 
variation; however, they can not be used to reduce the respondent specific bias in self-reported 
lifestyle and dietary habits. In future research, data on biomarkers in addition to self-reported 
information on lifestyle and dietary habits should be used to validate the self-reported values. 
Obviously, the choice of the most reliable biomarkers is very important in this context (48).
 Risk factors for sudden cardiac death are generally the same as those for atherosclerotic 
coronary disease (47). However, the studies described in this thesis showed that trans 
unsaturated fatty acid intake increased and fatty fish consumption decreased the risk of sudden 
coronary death, while no associations were found for total CHD death. For fish consumption, 
Albert et al. found in the US Physicians Health Study an association with sudden cardiac 
death and not with nonsudden cardiac death (49). Therefore, future research on sudden death 
should focus on identifying risk factors which may specifically predict sudden cardiac death as 
opposed to nonsudden cardiac death.
 Because CHD has been considered a disease predominantly affecting men, women were 
not included in older prospective cohort studies on CHD. Yet, women have a 30% life-time 
risk of CHD (50). Most risk factors for CHD are the same for men and women, but the impact 
of the individual risk factors might be different. Diabetes, HDL cholesterol and triglyceride 
levels may have a greater impact on CHD risk in women compared to men, while the effects 
of lipoprotein A seem to be stronger in men (51). The Zutphen Study was performed in men 
only, and future research is needed to evaluate whether the findings from this thesis are also 
applicable to women. 
Conclusions
The studies described in this thesis emphasize the importance of lifestyle and diet for public 
health in three ways. First, the results from this thesis suggest that non-smoking and the 
consumption of a small amount of wine decrease the risk of (cardiovascular) mortality and, 
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consequently, will increase life expectancy at age 50. However, since alcohol consumption can 
be addictive, starting to drink because of its positive health benefits can not be recommended. To 
increase life expectancy at age 50, most attention should be paid to quitting smoking. Second, 
the consumption of fatty fish and a reduction in trans unsaturated fatty acid intake may prevent 
sudden coronary deaths. Since the intake of trans unsaturated fatty acids has already decreased 
remarkably during the past years, the focus should be on encouraging the consumption of fatty 
fish for the prevention of sudden coronary deaths. Third, an increase in dietary fiber intake may 
reduce CHD mortality risk.
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From 1970 through 2007, life expectancy at birth increased steadily from 71 to 78 years among 
Dutch men. A major determinant for this increase in life expectancy is the decrease in the risk 
of dying from cardiovascular diseases (CVD). In the Netherlands, cardiovascular diseases are 
now the second leading cause of death among men. In 2007, about one-third of the men dying 
from CVD died from coronary heart disease (CHD) and another one-third from cerebrovascular 
diseases. Moreover, about 50% of the CHD deaths are sudden. The main aim of this thesis is 
to assess the relationships of recent and long-term exposure to known lifestyle and dietary risk 
factors with cardiovascular mortality and life expectancy. Data from a prospective cohort study 
were used to evaluate these relations. 
 In prospective cohort studies, information on lifestyle and dietary habits is generally 
only assessed at the baseline examination, assuming that these habits are relatively constant 
over the follow-up period of the study. Repeated measures can take into account changes in 
these habits, can reduce measurement error of the exposure as average exposure from multiple 
measurements has less within-subject variation, and can give more insight into the etiology 
of diseases. For the studies described in this thesis, we used data from the Zutphen Study, the 
Dutch contribution to the Seven Countries Study. The Zutphen Study is a prospective cohort 
study that has been carried out since 1960 among men born between 1900 and 1920. These 
men were examined repeatedly in seven examination rounds between 1960 and 2000. In every 
examination round, the men that took part in both the dietary and physical examinations were 
selected for the studies described in this thesis (n = 1373).
 Smoking habits and alcohol consumption are major risk factors for CVD and strong 
determinants of life expectancy. In chapter 2, we described the relationships of long-term 
cigarette, cigar or pipe smoking, and duration and the number of cigarettes smoked, with 
cardiovascular mortality and life expectancy. We found that both the number of cigarettes 
smoked and smoking duration were strongly associated with mortality risk. Compared to never 
or long-term former smoking, cigarette smoking decreased life expectancy by about 7 years 
and exclusive cigar or pipe smoking decreased life expectancy by about 5 years. Stopping 
smoking cigarettes at age 50 increased life expectancy by 3.3 years. The impact of long-term 
alcohol intake and different types of alcoholic beverages consumed on cardiovascular mortality 
and life expectancy is estimated in chapter 3. We observed that long-term light alcohol intake, 
i.e. <20 grams per day, compared to no alcohol intake, lowered cardiovascular (HR: 0.70 
[95% confidence interval: 0.55 to 0.89]) and all-cause (HR: 0.75 [0.63 to 0.91]) mortality risk. 
Compared to men who do not consume alcohol, wine consumers had a 5 years longer life 
expectancy.
 According to the classic diet-heart hypothesis, saturated fatty acids and dietary cholesterol 
raise plasma cholesterol levels, thereby causing CHD. More recently, studies have shown that 
the increased risk of CHD is not only due to an increase in serum cholesterol levels, but also to 
other factors such as inflammation. Furthermore, the intake of other dietary factors such as trans 
unsaturated fatty acids, fish and dietary fiber may influence the risk of CHD. In chapter 4, we 
describe the changes in trans unsaturated fatty acid intake during the 40 years of follow-up of 
the Zutphen Study. We observed that average intake of trans unsaturated fatty acids decreased 
from 7 to about 1 percent of energy intake between 1960 and 2000. Moreover, we related long-
term trans unsaturated fatty acids (chapter 4) and fish consumption (chapter 5) to (sudden) 
coronary death. We found that each additional 2 percent of long-term energy intake from trans 
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unsaturated fatty acids was positively associated with sudden coronary death (HR: 1.62 [1.01 
to 2.60]). In contrast, long-term fatty fish consumption was inversely associated with sudden 
coronary death (HR: 0.46 [0.27 to 0.78]). The strength of the association between long-term 
total fish consumption and CHD death decreased from age 50 (HR: 0.32 [0.13 to 0.80]) until 
age 80 (HR: 1.34 [0.58 to 3.12]). We observed no clear dose-response relationship between 
the intake of the n-3 fatty acids EPA and DHA, and (sudden) coronary death. In chapter 6, 
the impact of recent and long-term dietary fiber intake on coronary and all-cause mortality is 
described. We found that each additional 10 grams of recent dietary fiber intake was associated 
with a lower risk of CHD (HR: 0.83 [0.70 to 0.98]) and all-cause (HR: 0.91 [0.82 to 1.00]) 
mortality. 
 The findings from the studies described in this thesis are put into perspective in chapter 
7. The main aim of this thesis was to assess the relationships between recent and long-term 
exposure to known lifestyle and dietary factors on mortality. To better represent long-term 
exposure to lifestyle and dietary factors, we calculated cumulative average exposures. Averaging 
repeated measures reduces within-subject variation and, thereby, reduces measurement error. 
The use of repeated measures may also give more insight into the etiology of diseases. With 
the exception of dietary fiber intake, the effects of long-term exposure to lifestyle and dietary 
factors were stronger than those of recent exposure. This suggests that the long-term exposure is 
etiologically more important than recent exposure. However, this can not be said with certainty, 
as the stronger effects could also be due to the reduction in measurement error. On the other 
hand, the stronger effect of recent dietary fiber intake compared with the effects of long-term 
intake, indicates real etiological relevance of recent intake, as this cannot be explained by the 
effects of measurement error. Moreover, the use of repeated measures of lifestyle and dietary 
habits takes into account any changes in these habits during the course of life. It does, however, 
not reduce the systematic measurement error of the method used for collecting these data. 
 The findings from our studies emphasize the importance of lifestyle and diet for public 
health. The individual effects of alcohol and smoking are well established, but the combined 
effect of these factors on cardiovascular mortality and life expectancy remain unclear. Although 
the interaction between wine use and overall smoking was not statistically significant, the 
joint effect of wine use and not smoking on mortality was stronger than the individual effects. 
However, since alcohol consumption can be addictive, starting to drink because of its positive 
health benefits can not be recommended and most attention should be paid to quitting smoking. 
Because 50% of all CHD deaths are sudden, preventing sudden deaths by changes in lifestyle 
and dietary habits is of great public health importance. The consumption of fatty fish and a 
reduction in trans unsaturated fatty acid intake may prevent sudden coronary death; however, 
because the intake of trans unsaturated fatty acids has decreased remarkably during the past 
years, the focus should be on encouraging fatty fish consumption. 
 Future studies on the relationship between long-term exposure to known lifestyle and 
dietary factors on mortality should focus on separating the effects of reducing the measurement 
error, by averaging the exposure, from the etiological relevance. Moreover, future research 
should be done to identify risk factors which may specifically predict sudden coronary death as 
opposed to nonsudden coronary death and to evaluate whether the findings from this thesis are 
also applicable to women.
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In conclusion, our results suggest that non-smoking and a low level of wine consumption 
decrease the risk of (cardiovascular) mortality and will increase life expectancy at age 50. The 
long-term consumption of fatty fish and the reduction in long-term trans unsaturated fatty acid 
intake may prevent sudden coronary deaths, and a higher recent dietary fiber intake may reduce 
both CHD and all-cause mortality risk.
Summary in Dutch (Samenvatting)
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De levensverwachting bij geboorte van Nederlandse mannen is gestaag gestegen van 71 jaar 
in 1970 tot 78 jaar in 2007. Een belangrijke oorzaak van deze stijging in levensverwachting 
is de daling in de sterfte aan hart- en vaatziekten, die op dit moment in Nederland de één na 
belangrijkste doodsoorzaak is onder mannen. Van de mannen die in 2007 overleden aan hart- 
en vaatziekten, stierf ongeveer een derde als gevolg van coronaire hartziekten en een derde als 
gevolg van cerebrovasculaire aandoeningen. Daarnaast overlijdt 50% van alle overledenen aan 
coronaire hartziekten plotseling (plotse hartdood). Het belangrijkste doel van dit proefschrift 
is het bestuderen van de effecten van een recente en een langdurige blootstelling aan leefstijl 
en voedingsfactoren op sterfte aan hart- en vaatziekten en de levensverwachting. Voor het 
bestuderen van deze relaties werden gegevens uit een prospectief cohort onderzoek gebruikt. 
 In prospectieve cohort studies wordt informatie over leefstijl- en eetgewoonten meestal 
verzameld aan het begin van het onderzoek, ervan uitgaande dat deze gewoonten relatief 
constant blijven tijdens het onderzoek. Dit hoeft echter niet altijd zo te zijn. Door het gebruik 
van herhaalde metingen kan rekening worden gehouden met veranderingen in deze gewoonten 
in de tijd. Daarnaast kunnen herhaalde metingen de meetfout van de leefstijl- en eetgewoonten 
verkleinen, aangezien een gemiddelde blootstelling van meerdere metingen een kleinere 
variatie binnen personen heeft. Ook kan er meer inzicht worden verkregen in het belang van 
deze factoren voor het ontstaan van ziekten. Voor de onderzoeken die worden beschreven in dit 
proefschrift, hebben we gebruik gemaakt van gegevens van de Zutphen Studie, de Nederlandse 
bijdrage aan de Zeven Landen Studie. De Zutphen Studie is een prospectief cohort onderzoek 
dat is uitgevoerd vanaf 1960 onder mannen die geboren zijn tussen 1900 en 1920. Tussen 1960 
en 2000 zijn deze mannen zeven keer onderzocht. Voor de onderzoeken in dit proefschrift, zijn 
de mannen geselecteerd die in een meetronde zowel aan het voedingsonderzoek als ook aan het 
lichamelijk onderzoek hebben meegedaan (n = 1373).
 Roken en alcoholgebruik zijn belangrijke risicofactoren voor sterfte aan hart- en vaatziekten 
en sterke determinanten van de levensverwachting. In hoofdstuk 2 hebben we de effecten 
van het langdurig roken van sigaretten, sigaar of pijp, en van de duur en het aantal gerookte 
sigaretten, op sterfte aan hart- en vaatziekten en levensverwachting beschreven. Wij zagen 
dat zowel het aantal gerookte sigaretten als het aantal jaren dat er sigaretten werden gerookt, 
sterk geassocieerd waren met het sterfterisico. Vergeleken met mannen die nooit rookten of 
reeds een lange tijd gestopt waren met roken, was de levensverwachting van de mannen die 
sigaretten rookten ongeveer 7 jaar korter; voor mannen die alleen sigaar of pijp rookten was 
dit ongeveer 5 jaar. Door te stoppen met het roken van sigaretten op 50-jarige leeftijd nam de 
levensverwachting met 3,3 jaar toe. De gevolgen van een langdurige inname van alcohol en 
consumptie van verschillende soorten alcoholische dranken op sterfte aan hart- en vaatziekten 
en levensverwachting zijn beschreven in hoofdstuk 3. Langdurig licht alcoholgebruik, d.w.z. 
<20 gram per dag (<2 glazen per dag), verlaagde, vergeleken met geen alcoholgebruik, het risico 
op sterfte aan hart- en vaatziekten (Hazard Ratio [HR]: 0,70 [95% betrouwbaarheidsinterval: 
0,55 tot 0,89]) en het risico op totaal sterfte (HR: 0,75 [0,63 tot 0,91]). Vergeleken met mannen 
die geen alcohol gebruiken hadden wijn drinkers een 5 jaar hogere levensverwachting.
 De klassieke ‘voeding-hartinfarct’ hypothese gaat ervan uit dat verzadigde vetzuren en 
voedingscholesterol het cholesterolgehalte in het bloed verhogen waardoor het risico op het 
krijgen van coronaire hartziekten groter wordt. Recentelijk hebben studies aangetoond dat 
het verhoogde risico op coronaire hartziekten niet alleen te wijten is aan een toename van 
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het cholesterolgehalte in het bloed, maar ook aan andere factoren, zoals ontstekingprocessen. 
Bovendien kan de inname van andere voedingsfactoren, zoals trans onverzadigde vetzuren, vis 
en voedingsvezel, ook van invloed zijn op het ontstaan van coronaire hartziekten. In hoofdstuk 
4 beschrijven wij de veranderingen in de inname van trans onverzadigde vetzuren tijdens de 
40 jarige onderzoeksperiode van de Zutphen Studie. Tussen 1960 en 2000 is de gemiddelde 
inname van trans onverzadigde vetzuren gedaald van 7 tot ongeveer 1 procent van de totale 
energie inname. Daarnaast hebben wij gekeken of er een verband was tussen de langdurige 
inname van trans onverzadigde vetzuren (hoofdstuk 4) en de consumptie van vis (hoofdstuk 
5) en (plotselinge) sterfte aan coronaire hartziekten. Wij vonden dat iedere 2 procent extra 
aan langdurige inname van energie uit trans onverzadigde vetzuren was geassocieerd met een 
hoger risico op plotse hartdood (HR: 1,62 [1,01 tot 2,60]). In tegenstelling tot de inname van 
trans onverzadigde vetzuren, was de langdurige consumptie van vette vis geassocieerd met een 
lager risico op plotse hartdood (HR: 0,46 [0,27 tot 0,78]). De sterkte van het verband tussen de 
langdurige consumptie van vis en sterfte aan coronaire hartziekten nam af van 50-jarige (HR: 
0,32 [0,13 tot 0,80]) tot 80-jarige leeftijd (HR: 1,34 [0,58 tot 3,12]). We zagen geen duidelijke 
dosis-respons relatie tussen de inname van de n-3 vetzuren uit vis (EPA en DHA) en (plotselinge) 
sterfte aan coronaire hartziekten. In hoofdstuk 6 wordt het verband van een recente en een 
langdurige inname van voedingsvezel met sterfte aan coronaire hartziekten en totaal sterfte 
beschreven. Elke 10 gram extra recente inname van voedingsvezel was geassocieerd met een 
lager risico op sterfte aan coronaire hartziekten (HR: 0,83 [0,70 tot 0,98]) en totaal sterfte (HR: 
0,91 [0,82 tot 1,00]). 
 De resultaten van dit onderzoek worden in perspectief geplaatst in hoofdstuk 7. Het 
belangrijkste doel van dit proefschrift was om de verbanden van een recente en een langdurige 
blootstelling aan leefstijl en voedingsfactoren met sterfte te bestuderen. Om een langdurige 
blootstelling aan leefstijl en voedingsfactoren beter weer te geven, hebben wij een cumulatief 
gemiddelde blootstelling berekend. Door het middelen van herhaalde metingen vermindert de 
variatie van de blootstelling binnen personen, met als gevolg dat de meetfout van de blootstelling 
kleiner wordt. Door het gebruik van herhaalde metingen kan ook beter inzicht in het ontstaan 
van ziekten worden verkregen. Met uitzondering van de inname van voedingsvezel, waren 
de effecten van een langdurige blootstelling aan leefstijl en voedingsfactoren sterker dan die 
van een recente blootstelling. Dit suggereert dat een langdurige blootstelling belangrijker is 
voor het sterfterisico dan een recente blootstelling. Dit kan echter niet met zekerheid worden 
vastgesteld, aangezien de sterkere relaties van een langdurige blootstelling met sterfte ook 
het gevolg kunnen zijn van de verkleining van de meetfout. Aan de andere kant, het sterkere 
verband van de recente inname van voedingsvezel, in vergelijking met die van een langdurige 
inname, geeft aan dat de recente inname van voedingsvezel belangrijker is voor het sterfterisico, 
aangezien dit niet kan worden verklaard door effecten van de meetfout. Daarnaast kan door het 
gebruik van herhaalde metingen rekening worden gehouden met veranderingen van leefstijl 
en eetgewoonten tijdens de onderzoeksperiode. De herhaalde metingen bieden echter geen 
oplossing voor de systematische meetfout van de gebruikte methodes voor het verzamelen van 
deze gegevens. 
 De bevindingen van onze onderzoeken benadrukken het belang van leefstijl en voeding 
voor de volksgezondheid. De afzonderlijke effecten van alcohol en roken zijn goed beschreven, 
maar het gecombineerde effect van deze factoren op sterfte aan hart- en vaatziekten en 
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levensverwachting is nog onduidelijk. Hoewel de interactie tussen wijn consumptie en roken 
niet statistisch significant was, was het gezamenlijke effect van wijn consumptie en niet-roken 
op sterfte sterker dan de afzonderlijke effecten. Echter, aangezien de consumptie van alcohol 
verslavend kan zijn, kan het beginnen met drinken vanwege de positieve gezondheidseffecten 
niet worden aanbevolen en zal in preventie programma’s de meeste nadruk moeten worden 
gelegd op het stoppen met roken. Omdat 50% van de sterfte aan coronaire hartziekten plotseling 
plaatsvindt (plotse hartdood), is het voorkomen van plotse hartdood door veranderingen in 
leefstijl en eetgewoonten ook van groot belang voor de volksgezondheid. Onze resultaten 
laten zien dat de consumptie van vette vis en een verminderde inname van trans onverzadigde 
vetzuren plotselinge hartdood kan voorkomen. Echter, omdat de inname van trans onverzadigde 
vetzuren al opmerkelijk daalde in de afgelopen jaren, zal de nadruk moeten liggen op het 
stimuleren van vette vis consumptie. 
 In hoofdstuk 7 worden ook suggesties gegeven voor toekomstig onderzoek naar de relaties 
tussen langdurige blootstelling aan bekende leefstijl en eetgewoonten en sterfte. Toekomstig 
onderzoek zou zich moeten richten op het uit elkaar halen van de effecten van de verkleining 
van de meetfout, als gevolg van het gebruik van een gemiddelde blootstelling, en de meest 
relevante blootstellingperiode voor het ontstaan van ziekten en het sterfterisico. Bovendien 
zal gezocht moeten worden naar risicofactoren die specifiek plotselinge sterfte aan coronaire 
hartziekten (plotse hartdood) voorspellen in tegenstelling tot sterfte aan chronisch verlopende 
coronaire hartziekten. Daarnaast zal bekeken moeten worden of de bevindingen uit dit 
proefschrift ook van toepassing zijn op vrouwen. 
 Kortom, onze resultaten suggereren dat niet-roken en een lage consumptie van wijn de 
kans op sterfte aan hart- en vaatziekten verlaagt en de levensverwachting op 50 jarige leeftijd 
verhoogt. Langdurige consumptie van vette vis en vermindering van de langdurige inname 
van trans onverzadigde vetzuren kunnen plotse hartdood voorkomen. Bovendien kan een 
hogere inname van voedingsvezel de kans op sterfte aan coronaire hartziekten en totaal sterfte 
verkleinen.
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